This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
CO, Torr
0.85 0.80 0.75 0.70 0.65 0.60 0.55
0
0.1
0.2
0.3
0.4
0.5
0.6 C 0.7
Figure 20: The effect of foreign particle concentration on the average, partial pressure of CO inside the representative elementary volume of the alveolar region after ten seconds, for a single-breath test. DL
18 17 16 15 14 13 12
0
0.1
0.2
0.3
0.4
C
0.5
Figure 21: Lung-diffusing capacity versus concentration of single particles. Figure 20 shows the time evolution of CO partial pressure in the course of the single-breath transient simulation for the case of different values of the particle concentration (single particles only; there are no particle clusters in the domain). As seen from the figure, the value of the partial pressure increases nonlinearly with the increase of the particle concentration. The corresponding values of the lung-diffusing capacity are shown in Fig. 21. An interesting observation can be made by considering Fig. 21. It is clearly seen that the behavior of the curve changes at the value of concentration C = 0.12. The same effect was observed when different values of the red blood cells concentration were considered (see the preceding section). What is even more interesting is the prediction made by Wijayanto et al [20] (see also Chap. 5 of this book). It has been shown that the value C = 0.12 corresponds to the maximum value of
60 Human Respiration
L
D , ml of CO/(min mmHg)
16.5 16 15.5 1 ppc 2 ppc 3 ppc 4 ppc 5 ppc 6 ppc 7 ppc
15 14.5 14 13.5
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7 C 0.8
Figure 22: The effect of particle clustering on the lung-diffusing capacity [the numbers in the legend show the average number of particles per cluster (ppc)]. concentration to be achieved in the alveolar region during a single respiration cycle, if the value of concentration at the entrance to the trachea is equal to unity. The effect of particle clustering on the lung-diffusing capacity is shown in Fig. 22. From Fig. 22, it is possible to see that the value of the lung-diffusing capacity decreases monotonically with increased particle concentration. The effect of the particle clustering can be clearly observed from the figure: the value of the lungdiffusing capacity steadily decreases as the average number of particles per cluster increases. One can see, however, that, as the average number of particles per cluster increases, the effect on the lung-diffusing capacity becomes less pronounced. This can be explained by the fact that the larger the number of particles per cluster the more particles are shielded from participating in the diffusion process. This, in turn, leads to the lung-diffusing capacity value becoming less sensitive to the clustering effect. Nevertheless, it is necessary to bear in mind that, as the average number of particles per cluster increases, more red blood cells become screened from the gasexchange process. Hence, the absolute amount of CO remains large at the end of the single-breath test (see Fig. 20). Therefore, although values of the lung-diffusing capacity may remain large enough, the dose of CO obtained during a single respiration cycle becomes larger as the average number of particles per cluster increases. Thus, the effect of intoxication by CO may take place (this effect is quantified in Chap. 6 of this book). Exact values of the lung-diffusing capacity corresponding to different values of particle concentration and particle clustering are given in Table 2. In an attempt to quantify the effect of particles on the lung-diffusing capacity, it is possible to propose the following empirical relationship that fairly well describes the effect observed in the course of numerical simulations: DL (C; k) =
16.6 − 0.39k , 1 + 0.075C
(44)
Fundamentals of Alveolar Gas Diffusion
61
Table 2: Values of the lung-diffusing capacity corresponding to different values of particle concentration and particle clustering. C
1 ppc
2 ppc
3 ppc
4 ppc
5 ppc
6 ppc
7 ppc
0.050000 0.10000 0.20000 0.30000 0.40000 0.50000
16.215 16.159 15.979 15.854 15.572 15.334
16.190 16.121 15.884 15.703 15.380 15.022
15.897 15.783 15.583 15.392 15.182 14.956
15.769 15.446 15.139 14.867 14.605 14.478
15.185 14.930 14.491 14.200 14.071 13.946
14.514 14.127 13.876 13.753 13.743 13.733
13.874 13.721 13.638 13.638 13.638 13.638
where C is the particle concentration and k is the average number of particles per cluster. Thus, it has been shown how the presence of microscopic solid particles in the alveolar region affects the lung-diffusing capacity and, consequently, the overall lung performance. The effect of the particles clustering on the lung-diffusing capacity has also been investigated. It has been found that particle clustering moderately affects the value of the lung-diffusing capacity. However, due to the particles’ presence, more red blood cells become shielded from the gas-exchange process that leads to a larger amount of CO accumulated in the alveolar region. This may lead to a more pronounced intoxicating effect. In addition, an attempt was made to quantify the effect of the particles’ presence on the lung-diffusing capacity. An empirical relationship for doing so has been proposed (eqn. (44)).
3 Visualization of the results Bearing in mind the extreme geometrical complexity of the domain in question and the complexity of the solution itself, it becomes crucial to be able to visualize the results. Such an attempt is presented in this section. Volume visualization has been used for rendering when simulating the respiration process. The visualization of the model has been done with the free-ware software VolPack (The VolPack Volume Rendering Library). VolPack is a portable software library for volume-rendering based on the fast volume-rendering algorithms (Lacroute and Levoy [11]). Based on this library, we developed the software, which makes computer animation from the key-frame volume data calculated during the simulation. The software lets us interpolate the in-between frames, manipulate the volume on the screen with time-dependent affine transformations (rotation and zooming), and control the visual appearance of the volume (color and opacity). While the simulation software runs on a personal computer, the volume visualization subsystems runs on an SGI workstation remotely so that the resulting movie file
62 Human Respiration
Figure 23: Snapshots of the simulated video for four different RBC distributions. can be downloaded back to the PC for further post-production processing. The user may either control the process of rendering visually, or run it in the batch mode. Several video files for different RBC distributions have been created for this project (see Fig. 23). The streaming video versions of them are available on-line at http://www.ntu.edu.sg/home/assourin/Scivi.htm. The first row of snapshots in Fig. 23 represents the results obtained in the case of the random distribution of the red blood cells within the domain. The second and third rows represent the center- and corner-clustering cases, respectively; whereas the fourth row exemplifies the results obtained for the chain distribution. By comparing the four cases, one can clearly see that, in terms of the diffusion efficiency, the first and last cases are much more effective than the clustering cases. This can be explained by the presence of the so-called shielding effect. Indeed, when the red blood cells form clusters, those red blood cells that are nearer the center of the cluster become partly or totally excluded from the gas-exchange process. Hence, this process goes slower or, in other words, is less effective. It can be seen from the figure that the normal distribution is the most efficient one. This is not surprising because almost no screening effect is present in this case. It is noteworthy to point out here that a simple visual analysis of the results leads to the same conclusions that were drawn in the first section of this chapter after analyzing the results analytically. This proves that visualization is a very powerful analysis tool. Figure 24 presents a detailed view of the snapshots obtained upon visualizing the results corresponding to the case of the normal (random) distribution of the red blood cells within the alveolar region. From Fig. 24, one can clearly see that the diffusion process in the case of the randomly distributed red blood cells goes very fast: almost no carbon monoxide remains in the representative elementary volume at the middle of the test.
Fundamentals of Alveolar Gas Diffusion
63
Figure 24: Snapshots of the simulated video for the random distribution of RBC. Looking at the first row in the figure, one can see the distinct granular structure on the snapshots. This may serve as a measure of how many separate red blood cells participate in the gas-exchange process. Since almost all red blood cells in this case stay far from each other, all of them suck CO effectively, so that no shielding effect takes place. Note here that the snapshots corresponding to the uniform distribution of the red blood cells are not presented: the picture obtained is indistinguishable from the picture corresponding to the random (normal) distribution (Fig. 24). Both distributions have about the same effectiveness and their effect looks similar. This was explained in detail in the first section of this chapter. Figure 25 presents a detailed view of the snapshots obtained upon visualizing the results corresponding to the case of the central clustering of the red blood cells within the alveolar region. The effectiveness of the diffusion process in this case is very low. This can be seen by comparing the second and fourth rows in the figure: almost no difference in the snapshots is observed. The diffusing strength of the center cluster is not enough even to remove the test gas (carbon monoxide) from the corners of the representative elementary volume. The figure clearly shows that the gas exchange takes place mainly in the near vicinity of the cluster, so that the space freed from CO (the white spot on the snapshots) does not noticeably expand in the course of the test. Figure 26 presents a detailed view of the snapshots obtained upon visualizing the results corresponding to the case of the corner clustering of the red blood cells within the alveolar region.
64 Human Respiration
Figure 25: Snapshots of the simulated video for the center clustering of RBC.
Figure 26: Snapshots of the simulated video for the corner clustering of RBC. The result is similar to that observed in Fig. 25, except that, in this case, the red blood cells form the cluster in the front-upper corner of the representative elementary volume. This circumstance leads to an even lower effectiveness of diffusion that characterized the case of the center clustering. Indeed, fifty per cent
Fundamentals of Alveolar Gas Diffusion
65
Figure 27: Snapshots of the simulated video for the chain distribution of RBC.
of the red blood cells that form the boundary of the cluster are now excluded from the diffusion process (unlike in the previous case, where all the boundary cells participated in the gas exchange) (see the first section of this chapter for details). Figure 27 presents a detailed view of the snapshots obtained upon visualizing the results corresponding to the case of the chain distribution of the red blood cells within the alveolar region. The same granular structure that was observed in Fig. 24 can be seen on the two first snapshots of Fig. 27. Yet the linear patterns become pronounced starting from the second row of the snapshots. It can be clearly seen from the figure that the chain distribution is much more effective than the two clustering distributions considered previously. However, the effectiveness of the chain distribution is lower than the effectiveness of the normal (random) distribution of the red blood cells. This is because each red blood cell in the chain distribution has at least two neighbors that screen it partly from access to CO, whereas the probability to have neighbors in the case of the random (normal) distribution is much lower (see the first section of this chapter for details). Volume visualization proves to be useful for presenting the results obtained from direct single-breath test measurements or their numerical simulations. By the use of volume visualization, one can have a clearer picture of the lung performance in general and of the abnormalities of the diffusion process in particular. Volume visualization allows one to have an overall picture of the process that is impossible to have otherwise.
66 Human Respiration There is a hope that volume visualization of the microscopic gas exchange will become a powerful tool for pronouncing preliminary judgment on respiratory abnormalities. It is believed that further developments in this area may become useful for early diagnostics of obstructive respiratory diseases in different classes of patients.
Appendix A: Porous medium alveolar model Consider a volume in space representative, from a statistical point of view, of the alveolar region of the lung. The main structures (constituents) of this porous region are (see Fig. 4): the alveolus or gas region (a), the alveolus membrane (m), the interstitial fluid region (f ), the capillary membrane (c), the plasma region (p), the red blood cell membrane (r), and red blood cell interior (h). In treating the gas transport within the alveolar region, it is usual to lump regions m, f , c, and p into one single representative region, denominated here the tissue region (t), mainly because these constituents have comparable molecular gas diffusivities (Hsia et al, [8]). Moreover, the intricacies of the chemo-biological process within the red blood cell are avoided by considering a certain gas concentration (or partial pressure) uniformly distributed within h. The gas-diffusion transport is then driven, in principle, by a concentration imbalance between the gas concentration along the outer boundary of the alveolar region and the gas concentration within each red blood cell. The microscopic equation modeling the gas-diffusion transport within each alveolar constituent, can be written as: ∂c = −∇ · j + S, ∂t
(A.1)
where c is the representative concentration of solute (gas), j is the flux of solute into the medium (e.g., air mixture), and S is a source of solute (negative if sink). Considering a Fikian-type diffusion, the flux is related to the local gradient of gas concentration as j = −D∇c,
(A.2)
where D is the molecular diffusivity of solute into the solvent (D accounts also for the solubility of the gas in a nongaseous medium, e.g., within the tissue region). Equation (A.2) can be written in terms of the gas partial pressure, P (instead of gas concentration), by using the ideal gas law: P = c(RT /M ), where R is the universal gas constant, T is the temperature of the gas, and M is the molecular mass of the gas. The partial-pressure-based diffusion equation equivalent to eqn. (A.2) is P M j = −D M ∇ (T ∇P − P∇T ) . = −D R T RT 2
(A.3)
Fundamentals of Alveolar Gas Diffusion
67
Substitution of eqn. (A.3) into eqn. (A.1), with (DM/R) considered invariant in space and using the ideal gas law, leads to M R
1 ∂P P ∂T − 2 T ∂t T ∂t
2P DM 1 2 2 2 (∇T ) −2∇T · ∇P + T ∇ + S. P − P∇ T + = R T2 T
(A.4)
In the case of isothermal diffusion, as within the alveolar region of homeotherms, eqn. (A.4) simplifies to M M ∂P = D ∇ 2 P + S. TR ∂t TR
(A.5)
For a region with no source or sink, S = 0, and the groups M/TR cancel out. Considering now the three-constituent model of the alveolar region (i.e., alveolus (a), tissue (t), and red blood cell membrane (r)), one can write the equation and boundary conditions valid for each constituent in terms of the gas partial pressure. For the alveolus a-region: ∂Pa = Da ∇ 2 Pa , ∂t
(A.6)
where Pa and Da are the partial pressure and the molecular diffusivity of the gas within the alveolus region. This equation can be solved with an appropriate initial condition and boundary conditions Pa = P0 along A0a , where P0 is a representative partial-pressure value along the outer boundary surface area A0a of the alveolus, and Pa = Pt along the interface Aat between the alveolus and the tissue regions. For the tissue region: ∂Pt = Dt ∇ 2 P t , ∂t
(A.7)
where Pt and Dt are the partial pressure and the equivalent diffusivity of the gas within the tissue region, respectively. Boundary conditions in this case are Pt = Pr along the interface area Atr between the tissue and the red blood cell membrane regions, and nat · Dt ∇Pt = nat · Da ∇Pa .
(A.8)
Equation (A.8) represents a balance of gas flux across the alveolus/tissue interface surface area Aat , with normal unit vector nat . For the red blood cell membrane region: ∂Pr = Dr ∇ 2 P r , ∂t
(A.9)
68 Human Respiration where Pr is the gas partial pressure within the red blood cell membrane region, and Dr is the molecular diffusivity of the gas in the red blood cell membrane. Boundary conditions in this case are ntr · Dr ∇Pr = ntr · Dt ∇Pt ,
(A.10)
representing a balance of gas flux across the tissue/red blood cell membrane interface surface area Atr with normal unit vector ntr . The second and final boundary condition is Pr = Ph along the interface area Arh between the red blood cell membrane and the red blood cell interior region. In general, Ph is not known. However, when simulating the diffusion of CO within the lung (CO is the gas used in clinical tests to determine the lung-diffusing capacity), the partial pressure of CO within a red blood cell can be assumed zero, because the red blood cells behave effectively as an infinite sink for CO (Comroe et al [4]). Equations (A.6)–(A.10) with boundary conditions and appropriate initial conditions, can be used to simulate the diffusion process within the alveolar region. The difficulty is the need to describe (locate) precisely the region occupied by each constituent and the related interface surfaces. To circumvent this difficulty, one might consider a certain volume V of the alveolar region with representative dimension d , where d is much smaller than L (the characteristic length of the alveolar region within the lung), much larger than da (the characteristic alveolus dimension inside V ) and tc (the characteristic capillary bed thickness inside V ), and much larger than tr (the characteristic red blood cell membrane dimension). As defined, V is a representative elementary volume (REV) of the alveolar region. The alveolar region can be built by placing several regions like V next to each other. The fact that V is a REV of the alveolar region means that it contains all the necessary information for describing the physical properties of the alveolar region. Therefore, all constituents of the alveolar region must be represented in (or contained by) this REV. Inside this REV, there can be many alveoli and a long capillary bed with several red blood cells. Because the pore-level (alveolus-erythrocyte level, or microscopic level) solution of the diffusion equation within such a medium seems impractical at the moment, a model that predicts the diffusion process inside the alveolar region at the REV level is now considered. The model in question is developed by applying the method of volume averaging (Carbonell & Whitaker [3], Nozad et al [13], Whitaker [19]) to transform the effects of the internal geometry of the alveolar region from a microscopic level to a macroscopic representative elementary volume level (REV-level). This transformation does not come free: the mass-transfer interaction at every interface surface area between constituents within a REV must be accounted for and modelled. Let us initially define an intrinsic average of the partial pressure Pi as
Pi =
1 Vi
Pi dV , Vi
(A.11)
Fundamentals of Alveolar Gas Diffusion
69
where Vi is the volume within V occupied by constituent ‘i’ (‘i’ can be the alveolus a-region, the tissue t-region or the red blood cell membrane r-region). Now write Pi = Pi + P˜ i , where P˜ i is the space (within V ) variation of Pi from the volumeaveraged value Pi . After integrating eqns. (A.6), (A.7) and (A.9) within V , one obtains, respectively,
Va 2 1 Va ∂ Pa ˜ = Da ∇ Pa + ∇· nat Pa dA + nat · ∇ Pa dA V ∂t V V Aat Aat
Vt ∂ Pt = Dt V ∂t
Vt 2 1 ∇ Pt + V V
Vr ∂ Pr Vr 2 1 = Dr ∇ Pr + V ∂t V V
(A.12)
∇ · Ata nta P˜ t dA + Atr ntr P˜ t dA + Ata nta · ∇ Pt dA + Atr ntr · ∇ Pt dA
∇· Art
nrt P˜ r dA +
(A.13)
nrt · ∇ Pr dA
.
Art
(A.14)
Equations (A.12), (A.13) and (A.14) are the REV-averaged diffusion equations for alveolus, tissue, and red blood cell membrane regions, respectively. Now, all three equations are added term by term keeping in mind that: Va + Vt + Vr = V , and, nij = −nji . The resulting equation, simplified further by invoking the equilibrium assumption, i.e., Pa = Pt = Pr = P (where P is the representative – effective – partial pressure within V ), and P˜ i = P˜ j (along Aij , where ‘i’ and ‘j’ can be a, t, or r), is ∂ P = ∂t
Vt Vr Va Da + Dt + Dr ∇ 2 P V V V
1 (Da − Dt ) ∇ · + n at P˜ a dA + (Dt − Dr ) ∇ · n tr P˜ t dA V Aat Atr (A.15)
The difficulty in applying eqn. (55) for modeling the diffusion process still lies on describing precisely the location of the interface surface areas Aat and Atr . We ˜ namely proceed with a closure constitutive equation for the perturbation term P, nij P˜ i dA = di ∇ P, (A.16) Aij
where di is a pseudodiffusion coefficient (a tensor, in general), considered here to be uniform and isotropic. Note that the form of the closure, eqn. (16), proposed by Nozad et al (1985) when modeling heat conduction in porous media, is similar in scope to the eddy-diffusivity concept used in modeling turbulence (i.e., a pseudodiffusivity can be defined as the ratio between the fluctuating quantity and the
70 Human Respiration gradient of the related average quantity). Substituting eqn. (A.16) into eqn. (A.15) and after rearranging the terms: ∂ P = Deff ∇ 2 P, ∂t
(A.17)
where Deff is the effective mass diffusivity coefficient of the REV, formally defined as 1 Va Vt Vr Da + Dt + Dr + [(Da − Dt )da + (Dt − Dr )dt ] . (A.18) Deff = V V V V Observe that once Deff is known, eqn. (A.17) is easily solved by applying a suitable initial condition (in terms of P) and boundary conditions, for instance,
P = P0 along the outer surface of the alveolar region, and P = Ph within the region occupied by the red blood cells inside the alveolar region of the lung. One does not need to know the effective diffusivity of the alveolar region when considering a steady diffusion process. In this case, eqn. (A.17) reduces to the Laplace equation in P. This detail is explored in section 1.6.1, where the numerical simulation of the steady diffusion process in an alveolar region is discussed. Appendix B: Relationship between the lung-diffusing capacity and the effective diffusion coefficient of the alveolar region: unifying theory The lung-diffusing capacity DL , measured in the laboratory (using CO) and available in the literature (Comroe et al [4], pp. 117–133), is defined as ◦
DL =
V , ( P0 − Ph )
(B.1)
◦
where V is the volumetric gas flow rate crossing the outer surface of the alveolar region (gas uptake) and P0 is the mean alveolar partial pressure of CO. It is easy to verify that the volumetric flow rate is related to the absolute value of the mass flux js crossing the boundary (surface) of the domain, via ◦
V = js As
RT M,
P b
(B.2) ◦
where As is the total surface area through which js flows. Eliminating V between eqns. (B.1) and (B.2), setting Pb = P0 , and using js = (Ai /As )Deff (M /RT ) (|∇ Ps |), Ai 1 DL = Deff ∇ Ps , (B.3)
Pb − Ph P b where Ai is the node surface area. The group [As ( Pb − Ph )/(Ai ∇ Ps )] represents the characteristic diffusion length of the domain.
Fundamentals of Alveolar Gas Diffusion
71
For a certain domain geometry, RBC distribution, red blood cell density ρ and known (measured) DL value, one can then use eqn. (B.3) to determine numerically an estimate of the effective lung diffusivity of the medium. This effectivediffusivity estimate can be used with the macroscopic model, eqn. (A.17), to simulate the transient diffusion process within the cubic alveolar region. Equation (B.3) provides only estimates of Deff because the equation depends on the surface gradient, a quantity obtainable only from a steady-state model (because Deff is not known). Recall that DL is obtained from transient experiments. (Note: even though one of the experimental schemes to measure DL is termed the steadystate technique – Comroe et al [4], p. 121 – the diffusion process during measurement is still inherently unsteady because of the periodicity of the respiration process.) On the other hand, if Deff is known, one can, for instance, change the form of the domain or the RBC distribution (keeping the same red blood cell density), find the ∇ Ps value for the new configuration, and then use eqn. (B.3) to determine the corresponding DL of the new domain. In this way, one can now anticipate (predict) the effect on DL of a certain change in the morphology of the alveolar region.
Appendix C: Lumped-capacity approach to the alveolar diffusion The Krogh equation can be derived from a lumped-capacity approach to the diffusion process inside the alveolar region (Comroe et al [4], p. 351). (Observe that the hint for exploring a lumped-capacity approach emanates from the time evolution of Pv being exponential, as illustrated in Fig. 15.) To derive the Krogh equation from the lumped-capacity approach, consider the alveolar region as a closed impermeable system of volume VA , filled with a gas having a certain concentration of CO. The volumetric rate of CO being depleted (sink) from inside this system, expressed in terms of the lung-diffusing capacity, is ◦
V CO = DL ( P0 − Ph ) .
(C.1)
Observe that P0 in eqn. (C.1), in the case of a transient configuration, is in fact
Pv (t). Also recall that Ph for the case of CO diffusion can be considered equal to zero. Now, the species concentration conservation law, assuming the gas concentration within the domain as uniform, requires m ˙ = VA
d cv (t) , dt
(C.2)
where m ˙ CO is the CO depleting mass flow rate and cv is the volume average of the macroscopic gas concentration within the domain.
72 Human Respiration Equations (C.1) and (C.2) can be combined by setting m ˙ CO t V˙ CO (t) = , cref
(C.3)
where cref is a constant reference-gas concentration value. Using eqns. (C.1) and (C.2), eqn. (C.3) becomes DL Pv (t) = −
VA d cv (t) . cref dt
(C.4)
The last term of eqn. (C.3) can be rewritten in terms of the partial pressure of CO, using the ideal gas law (c = MP/RT ), then DL Pv (t) = −
VA d Pv (t) . Pref dt
(C.5)
Solving eqn. (C.5),
Pv (t) = Pv (0)e
−
DL Pref VA
t
,
(C.6)
where Pv (0) is the initial value of the volume-averaged partial pressure. When the reference pressure Pref is chosen as the total pressure of dry gases (equal to 9.51 × 104 Pa, or 713 mmHg), eqn. (C.6) becomes identical to the Krogh equation (Comroe et al [4], p. 351). The characteristic time constant for the diffusion process, according to eqn. (38), is VA /(DL Pref ), typically equal to 24.4 s (using VA = 4930 ml, DL = 17 mlCO /mmHg min, and Pref = 713 mmHg). This means that it takes approximately 25 seconds for the volume-averaged partial pressure of CO (or concentration) in the lungs to be reduced to 37.3 per cent of the initial value. Note that using the diffusion and solubility laws (Comroe et al [4], p. 350), it is possible to show that the lung-diffusing capacity of oxygen is about 1.23 times the diffusing capacity of carbon monoxide. Therefore, the characteristic time for diffusion of oxygen is approximately equal to 20 seconds. Observe how the solution of eqn. (C.6) leads to an exponential decay of Pv with time. The lung-diffusing capacity can be obtained easily from the numerical results (Fig. 10), via
VA
Pv (0) ln . (C.7) DL = Pref t
Pv (t) During clinical single-breath tests, eqn. (C.7) is used for determining the lungdiffusing capacity considering the alveolar volume VA as equal to the inspired volume plus the residual lung volume. It is easy to determine a condition for the validity of the lumped-capacity approach by considering the definition of the lung-diffusing capacity as equivalent to the
Fundamentals of Alveolar Gas Diffusion
73
definition of the mass-transfer coefficient from Newton’s law of cooling. In this regard, one has m ˙ CO = cref DL ( Pv − Ph ) =
( Pv − Ph ) . RD L
(C.8)
Therefore, the equivalent resistance RDL is simply 1/(cref DL ). The representative resistance of the internal diffusion process is m ˙ CO ∼ ADeff
M ( Pv − Ph ) ( Pv − Ph ) , = RT
RDeff
(C.9)
where is a representative (scale) diffusion length for the diffusion in the global (Krogh) domain and A is the representative area of the alveolar region (a good candidate for this area would be the surface area of all RBCs inside the domain). Therefore, the equivalent resistance RDeff is RT /(ADeff M ). For the lumped-capacity approach to be valid, one would expect RDL to be larger than RDeff . Using eqns. (C.8) and (C.9), the criterion becomes cref RT DL
DL ∼ Pref < 1, M A Deff A Deff
(C.10)
where estimates for parameters are Pref ∼ 105 Pa, /A ∼ 10−1 /[0.034(10−1 )3 (6/12 × 10−6 )] ∼ 10−3 m−1 , DL ∼10−9 m3 /s Pa, Deff ∼ 10−7 m2 /s, and the left side of the inequality shown in eqn. (C.10) becomes approximately equal to 1.0. This result indicates that the lumped-capacity model is close to not being valid. Observe, from Fig. 10, that the curve γ versus t does not follow the perfectly straight dashed line. Keep in mind that because the time duration of the clinical single-breath test is generally short (about 10 seconds), the deviation from the lumped-capacity model might not be easily observed.
References [1] American Thoracic Society, Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique, American Review of Respiratory Disease, 136, pp. 1299–1307, 1987. [2] Burri, P.H., Gil, J. & Weibel, E.R., Ultrastructure and Morphometry of Human Lung, General Thoracic Surgery, Vol. 1, 4th edn, Williams & Wilkins, 1996. [3] Carbonell, R.G. & Whitaker, S., Heat and mass transfer in porous media. Fundamentals of Transport Phenomena in Porous Media, eds. J. Bear & M.Y. Corapcioglu, Martinus Nijhoff, Dordrecht, The Netherlands, pp. 123– 198, 1984. [4] Comroe, J.H., Forster, R.E., Dubuis, A.B., Briscoe, W.A. & Carlsen, E., The Lung Clinical Physiology and Pulmonary Functions Tests, Chicago, Year Book Medical Publisher, pp. 117–121, 1962.
74 Human Respiration [5]
[6]
[7] [8]
[9]
[10]
[11]
[12]
[13]
[14] [15]
[16] [17] [18]
[19]
Crapo, J.D. & Crapo, R.O., Comparison of total lung diffusion capacity and the membrane component of diffusion capacity as determined by physiologic and morphometric techniques, Respiratory Physiology, 51, pp. 183–194, 1983. Crapo, J.D., Crapo, R.O., Jensen, R.L., Mercer, R.R. & Weibel, E.R., Evaluation of lung diffusing capacity by physiological and morphometric techniques, Journal of Applied Physiology, 64, pp. 2083–2091, 1988. Fedrespiel, W.J., Pulmonary diffusing capacity: implications of two-phase blood flow in capillaries, Respiratory Physiology, 77, pp. 119–134, 1989. Hsia, C.C.W., Chuong, C.J.C. & Johnson, R.L. Jr., Critique of conceptual basis of diffusing capacity estimates: a finite element analysis, Journal of Applied Physiology, 79, pp. 1039–1047, 1995. Johnson, R.L. Jr., Spicer, W.S., Bishop, J.M. & Forster, R.E., Pulmonary capillary blood volume, flow, and diffusing capacity during exercise, Journal of Applied Physiology, 15, pp. 893–902, 1960. Koulich (Kulish), V.V., Lage, J.L., Hsia, C.C.W. & Johnson, R.L. Jr., A Porous Medium Model of Alveolar Gas Diffusion, Journal of Porous Medium, 2, pp. 263–275, 1999. Lacroute, P. & Levoy, M., Fast Volume Rendering Using a Shear-Warp Factorization of the Viewing Transformation, Proceedings SIGGRAPH ’94, pp. 451–458, 1994. Newth, C.J.L., Cotton, D.J. & Nadel, J.A., Pulmonary diffusing capacity measured at multiple intervals during a single exhalation in man, Journal of Applied Physiology, 43, pp. 617–625, 1977. Nozad, I., Carbonell, R.G. & Whitaker, S., Heat conduction in multiphase systems 1: Theory and experiments in two-phase system. Chemical Engineering Science, 40, pp. 843–855, 1985. Philips Compact Encyclopedia, 1999, 2nd edn, Octopus Publishing Group Ltd: London. Roughton, F.J.W. & Foster, R.E., Relative importance of diffusion and chemical reaction rates in determining the rate of exchange of gases in the human lung, with special reference to true diffusing capacity of the pulmonary membrane and volume of blood in lung capillaries, Journal of Applied Physiology, 11, pp. 290–302, 1957. Shields, T.W., General Thoracic Surgery, Williams & Wilkins: Baltimore, 1994. Weibel, E.R., Morphometric estimation of pulmonary diffusion capacity. I. Model and method, Respiratory Physiology, 11, pp. 54–75, 1970. Weibel, E.R., Federspiel, W.J., Fryder-Doffey, F., Hsia, C.C.W., Konig, M., Stalder-Navarro, V. & Vock, R., Morphometric model or pulmonary diffusing capacity. I. Membrane diffusing capacity, Respiratory Physiology, 93, pp. 125–149, 1993. Whitaker, S., Improved constraints for the principle of local thermal equilibrium. Industrial Engineering Chemistry Research, 30, pp. 983–987, 1991.
Fundamentals of Alveolar Gas Diffusion
75
[20] Wijayanto, B., Kulish, V.V. & Lim Chu Sing, Modeling of Two-Phase Flow in the Human Tracheo-Bronchial System. Singapore General Hospital Proceedings, 11(1), pp. 40–46, 2002. [21] The VolPack Volume Rendering Library, http://graphics.stanford.edu/software/volpack/ [22] Streaming video files for different RBC distributions, http://www.ntu.edu.sg/ home/assourin/Scivi.htm
This page intentionally left blank
CHAPTER 3 Lung-gas composition and transfer analysis: O2 and CO2 diffusion coefficients and metabolic rates D.N. Ghista1 , K.M. Loh2 & D. Ng3 1 School
of Mechanical and Production Engineering, Nanyang Technological University, Singapore 639798; email:mdnghista@ntu,edu.sg 2 School of Engineering (Electronics), Nanyang Polytechnic, Singapore. 3 Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore.
Abstract The primary function of the lung is to (i) oxygenate the blood and thereby provide oxygen to the cells for metabolization purposes, and (ii) to remove the collected CO2 from the pulmonary blood. Herein, we will analyze the compositions of the inspired and expired air per breath, and from there compute the O2 consumption and CO2 production rates. Next, we derive expressions for diffusion coefficients DO2 and DCO2 in terms of the evaluated cardiac output, O2 and CO2 concentrations in arterial and venous blood, alveolar and blood O2 and CO2 partial pressures. We then take up a typical case study, and demonstrate the computation of DO2 and DCO2 , to represent the lung-performance capability to oxygenate the blood.
1 Introduction The lung-functional performance is characterized by (i) its ventilatory capacity, to bring air (and hence O2 ) into the alveoli, and (ii) its capacity to transfer O2 and CO2 into and from the pulmonary capillary bed. Hence, the O2 and CO2 diffusion coefficients as well as the O2 consumption rate and the CO2 production rate represent the lung-performance indices.
78 Human Respiration
2 Lung-air composition analysis (and O2 consumption and CO2 production rates) We carry out a mass-balance analysis, involving: (i) (ii)
compositions of air breathed in and out consumption or losses of O2 , CO2 and H2 O.
Table 1 provides clinical data on partial pressures and volumes of N2 , O2 , CO2 and H2 O of atmospheric air breathed in and expired out, one breath cycle. The monitored breathing rate (BR) = 12 breaths/min, and we assume PH2 O at 37◦ C = 47 mmHg. It can be noted that the expired air volume exceeds the inspired air volume for this particular breath cycle. The H2 O loss of 30.1 ml (=32.6–2.5 ml) contributes the major portion of this difference. 2.1 Calculation of O2 consumption rate and CO2 production rate We now determine the O2 consumption rate and CO2 production rates from the inspired and expired gases. Assuming the patient breathes at 12 times per minute we have O2 Consumption Rate = (Inspired O2 − Expired O2 ) × 12 = (104.2 − 80.6) × 12 = 283.2 ml/min
Table 1: Inspired air composition and partial pressures. Atmospheric air Respiratory gases
mmHg
N2
597
O2
159
CO2
0.3
H2 O
3.7
Total
760
Expired air
ml/%
mmHg
ml/%
393.1 78.55% 104.2 20.84% 0.2 0.04% 2.5 0.49% 500 100%
566
393.1 74.5% 80.6 15.7% 19.1 3.6% 32.6 6.2% 525.3 100%
120 27 47 760
Lung-Gas Composition and Transfer Analysis
79
Dead space (150 ml)
Figure 1: Dead-space volume CO2 Production Rate = (Expired CO2 − Inspired CO2 ) × 12 = (19.1 − 0.2) × 12 = 226.8 ml/min The amount of water vapor in the humidified expired air amounts to 6.2% of the expired air (compared to 0.49% of the dry inspired air) corresponding to the partial-pressure ratio of water vapor in the expired air (= 47/760). The volume of the dry expired air = (525.3 − 32.6) ml = 492.7 ml. Now, assume that out of 500 ml of inspired air, the dead-space air volume (not taking part in the gas-transfer process) is 150 ml and the alveolar air volume is 350 ml. We next compute the dead-space air volume composition. 2.2 Dead-space air composition The clinical data of expired air composition is: N2 = 393.1 ml O2 = 83.36 ml CO2 = 16.87 ml H2 O = 34.15 ml Total = 527.49 ml Now, the dead-space air will be made up of (i) a dry air portion from the inspired air (assumed to be = 141 ml), plus (ii) the water vapor taken up by the dry air
80 Human Respiration (estimated to be = 9 ml) since the expired air portion of 141 ml will not have under gone O2 and CO2 transfer, its composition is the same as that of the inspired air: N2 = 111 ml (78.55%), O2 = 29.40 ml (20.84%), CO2 = 0.06 ml (0.04%), H2 O = 0.69 ml (0.49%). When this inspired air (in the dead space) of 141 ml is fully humidified, it will take up a further X ml of H2 O vapor, in the ratio of the partial-pressures, as: X 47 = = 0.0659 141 713 ∴ X = 0.0659 × 141 = 9.29 ml of H2 O vapor (which is close to our estimate). So, by adding 9.29 ml of H2 O vapor to 0.69 ml of water vapor in the inspired air volume of 141 ml, the total water vapor in the dead-space air is 9.98 ml. The humified dead-space air composition will be: N2 = 111.00 ml O2 = 29.40 ml
(= 73.78%) (= 19.55%)
CO2 = 0.06 ml
(= 0.04%)
H2 O = 9.98 ml
(= 6.63%)
Total = 150.44 ml
2.3 Alveolar-air composition and partial pressures We can now compute the alveolar air composition, by subtracting the dead-space air from the expired air. These values are tabulated in column 4 of the table below. Finally, we compute the partial pressure of O2 and CO2 (as well as of N2 and H2 O), so that we can determine next the diffusion coefficients of O2 and CO2 based on the monitoring of arterial and venous blood concentrations. These values are tabulated in column 5 of the below table.
N2 O2 CO2 H2 O Total
Expired air (ml)
Dead-space air (ml)
Alveolar air (ml)
Alveolar-air partial pressure (mmHg)
393.1 80.53 19.12 34.21 526.96
111.00 29.40 0.06 9.98 150.44
282.1 51.13 19.06 24.23 376.52
569.41 103.21 38.47 48.91 760
Lung-Gas Composition and Transfer Analysis
81
3 Lung gas-exchange model and parametric analysis 3.1 Expressions for DO2 and DCO2 The gas exchange between the alveolar air and pulmonary capillary blood is represented by the following O2 and CO2 conservation equations (Fig. 2): ◦
Q VE COVE = QAE COAE + V O2 (from the alveolar air to capillary blood) 2 2 O cap AE 2 D + Pav PO2 = PO , (1) = QAE COAE O2 ; 2 2 cap
PRB (O concentration of the preoxygenated blood) in which PO2 = PO 2 2 ◦
VE AE QVE CCO = QAE CCO − V CO2 2 2 CO AE 2 D = QAE CCO − Pav CO2 ; 2
cap
VE PCO2 = PCO , 2
(2)
cap
PRB (CO concentration of the preoxygenated blood), in which PCO2 = PCO 2 2 wherein
QAB and QVB are arterial and venous blood flow-rates; QAB = QVE (at venous end), QVB = QAE (at arterial end) al and P cap are the alveolar and capillary O partial pressures (ii) PO 2 O2 2 al and P cap are the alveolar and capillary CO partial pressure (iii) PCO 2 CO2 2 (iv) DO2 and DCO2 are the O2 and CO2 diffusion coefficients O2 al − P cap ) over the capillary length; = average of (PO (v) Pav O2 2 (i)
cap
CO2 al − P = average of (PCO Pav O2 ) over the capillary length. 2 Now we can equate the arterial and venous blood flow rates, as
Q AB = QVB = Q = (SV)/(EP) CO/60, SV, EP and CO being the stroke volume, ejection period and cardiac output, respectively. Hence the above equations can be rewritten as: ◦ (vi) V O2 is the O2 transfer rate from alveolar air to capillary blood (= O2 con◦ sumption rate), V CO2 is the CO2 transfer rate from capillary blood to alveolar air.
Figure 2: Schematic of blood-gas concentration in the pulmonary capillary.
82 Human Respiration From eqn. (1): O cap AE 2 D QVE COVE = QAB COAB + Pav O2 ; PO2 = PO2 = PO2 2 2 O 2 D QCOVB = QCOAB + Pav O2 2 2 DO 2 =
Q(COVE Q(COAB − COAE ) − COVB ) 2 2 2 2 = . O2 O2 Pav Pav
(3)
From eqn. (2): CO cap VE AE AE VB 2 D = QAE CCO − Pav QVE CCO CO2 ; PCO2 = PCO2 = PCO2 2 2 AE CO2 QCOVE = QCCO − Pav DCO2 2 2 DCO2 =
VE − C AB ) Q(CCO CO2 2 . CO2 Pav
(4)
wherein VE and C AE can be monitored because Q, COVE and COAE , CCO CO2 2 2 2 VE = C AB and C AB and C AE and C AE = C VB and C VB COVE and C CO O CO O2 CO2 O2 CO2 2 2 2 2 (ii) DO2 and DCO2 (eqns. (3) and (4)) represent the lung gas-exchange parameters.
(i)
Now from eqns. (3) and (4), if we want to evaluate the diffusion coefficients DO2 and al , P cap and P al , P cap in terms of monitorable DCO2 , we need to also express PO O2 CO2 CO2 2 quantities. In this regard, ◦
◦
al can be expressed in terms of V (the ventilation rate) and V (i) Alveolar PO O2 2 (the O2 consumption rate) as Fig. 3:
◦ ◦ ◦ −k2 (V /V m )/V O2
al = k1 1 − e PO 2
,
◦
(5)
◦
where V m is the maximum ventilation rate and V O2 (the O2 consump− COVB ). Equation tion rate or absorption rate from the alveoli) = Q(COAB 2 2 ◦
◦
(5) implies that as (V /V m ) increases, (the exponential term decreases, and) al increases (as in Fig. 3), and as V◦ al PO O2 increases PO2 decreases (as in Fig. 3). 2 ◦
◦
al can be expressed in terms of V and V (ii) Alveolar PCO O2 as in Fig. 4. 2
◦ ◦ ◦ −k4 (V /V m )/V CO2
al PCO = k3 e 2
,
(6)
◦
where V CO2 (the CO2 production rate or excretion rate from the blood) = VB − C AB ). This equation implies that as V◦ /V◦ al Q(CCO m increases, PCO2 CO2 2 ◦
decreases; also, as V CO2 increases (the exponential term decreases, and al increases. hence) PCO 2
Lung-Gas Composition and Transfer Analysis
83
Figure 3: Effect on alveolar PO2 of (i) alveolar ventilation, and (ii) rate of oxygen absorption from alveolar PO2 or O2 consumption rate [from Guyton (1971), p. 476].
Figure 4: Effect on alveolar PCO2 of alveolar ventilation and rate of carbon dioxide excretion from the blood or CO2 production rate [from Guyton (1971), p. 476]. (iii)
Blood PO2 can be obtained in terms of blood CO2 , from the O2 disassociation curve (providing concentrations in arterial and venous blood), is represented in Fig. 5 as:
PO
−k5 P m2
CO2 = COm2 1 − e
O2
, or
∗ −k5 PO
CO∗ 2 = 1 − e
2
,
(7)
84 Human Respiration
Figure 5: O2 dissociation curves, showing the total oxygen in each 100 ml of normal blood, the portion dissolved in the water of the blood [from Guyton [2], p. 485].
Figure 6: The carbon dioxide dissociation curve [from Guyton [2], p. 491].
where m are the maximum values of blood O partial pressure • COm2 and PO 2 2 ∗ • CO2 = CO2 /COm 2 ∗ = P /P m . • PO O2 O2 2
(iv)
Blood PCO2 can be obtained in terms of CCO2 , from the CO2 disassociation curve or CO2 concentration in arterial and venous blood can be represented
85
Lung-Gas Composition and Transfer Analysis
as per Fig. 6 as: −k P /P m CCO2 = COm2 1 − e 6 CO2 CO2
or,
∗ CCO 2
=1−e
m −k6 PCO2 /PCO 2
∗ −k6 PCO
=1−e
2
(8)
.
3.2 Alveolar O2 and CO2 partial-pressure expressions al partial pressure curve (Fig. 3), represented by Now, let us refer eqn. (4) for the PO 2 the equation:
◦ ◦ ( ◦ V O2 −k2 V /V m al = k1 1 − e PO 2
◦ (◦ −k2 V ∗ V O2
◦
◦ , where V ∗ = ◦V Vm
= k1 1 − e ◦
(9)
◦
where V is the alveolar ventilation rate (in liters/min), V m is the maximum venti◦ lation rate (= 50 l/min) and V O2 is the O2 consumption rate (in liters/min). Herein, the coefficients k1 and k2 can be determined by having this equation match the ◦ al = 0 from the equation, which Fig. 3 data. Note, in this equation, when V = 0, PO 2 satisfies the data. ◦ ◦
◦
Now for V O2 = 0.25 l/min, when V ∗ =
140 = k1 ◦
−k2
1−e
V
◦
Vm
0.5 0.25
al = 140 mmHg. Hence, = 0.5, PO 2
= k1 (1 − e−2k2 ).
(10)
◦
al = 100 mmHg. Hence Also, when V O2 = 1 l/min, V ∗ = 0.3 l/min, PO 2
−k 0.3 100 = k1 1 − e 2 1 = k1 (1 − e−0.3k2 ).
(11)
From eqns. (10) and (11), we get: k1 (1 − e−2k2 ) 1 − e−2k2 140 = = −0.3k 2) 100 k1 (1 − e 1 − e−0.3k2 ∴ 140 − 140e−0.3k2 = 100 − 100e−2k2 or, 40 = 100e−2k2 + 140e−0.3k2 , so that k2 = 4.18 min/l. Upon substituting k2 = 4.18 min/l into eqn. (10) we obtain: 140 = k1 1 − e−(2×4.18) , so that k1 ≈ 140 mmHg.
(12)
(13)
86 Human Respiration al curve can be represented by: Hence, the PO 2
◦ (◦ −4.18 V ∗ V O2
,
al PO = 140 1 − e 2
◦
◦
(14)
◦
where, V O2 = Q(COAB − COVB ) and V ∗ = V /50 l/min. 2 2 al Now, let us look at the PCO2 expression: −k4
al PCO = k3 e 2
◦ ◦ ( ◦ V CO2 V /V m
= k3 e
◦
◦ (◦ −k4 V ∗ V CO2
.
◦
al = 12. Hence, We note from Fig. 4 that for V CO2 = 0.2 l/min and V m = 0.2, PCO 2 from the above equation, we get:
12 = k3 e−k4 ◦
(15)
◦
al = 62 mmHg. Hence Also, for V O2 = 0.8 l/min and V m = 0.2, PCO 2 −k4
62 = k3 e
0.20 0.80
= k3 e
−k4 4
(16)
.
From eqns. (15) and (16), we get: 2 12 e−k4 = −k = e− 3 k4 4 62 e 4 12 2 ln = − k4 , so that k4 = 2.46. 62 3
(17)
Substituting k4 = 2.46 into eqn. (16), we obtain: 62 = k3 e
−2.46 4
,
∴ k3 = 114.68.
(18)
al curve can be represented as Hence, the PCO 2
al = 114.68e PCO 2
◦ ◦ ( ◦ V CO2 V /V m
−2.46
,
◦ ◦) ◦ VB − C AB ). where V ∗ = V 50 l/min and V CO2 = Q(CCO CO2 2
3.3 Arterial and venous O2 and CO2 partial-pressure expressions AB and P VB in terms of C AB and C VB . We now need to express PO CO2 O2 CO2 2
(19)
Lung-Gas Composition and Transfer Analysis
87
So that let us look at the O2 disassociation curve, as shown in Fig. 5. ) CO2 = CO2 | max 1 − e−k5 PO2 PO2 | max , CO∗ 2 = 1 − e
or,
where CO∗ 2 = ∗ = From Fig. 5, at PO 2
∗ −k5 PO
2
CO2 CO2 | max
,
∗ , PO = 2
PO2 PO2 | max
(20)
.
40 mmHg = 0.29 (for normal venous blood), and 140 mmHg CO∗ 2 =
15 = 0.75. 20
Hence from eqn. (20): 0.75 = 1 − e−0.29k5 ∴ k5 = 4.78. ∗ = Also, PO 2
(21)
95 mmHg = 0.68 (for normal arterial blood), and 140 mmHg CO∗ 2 =
19 = 0.95. 20
Hence from eqn. (20): 0.95 = 1 − e−0.68k5 , or
k5 = 4.4.
(22)
So, we take the average value of k5 : ∴ k5 =
(4.78 + 4.4) = 4.59. 2
Then the O2 disassociation curve is given by: CO2 = and P O2
COB2
−4.59
= 0.21 − e
PO 2 140
(23)
,
(24)
0.2 0.2 140 ln = 30.5 ln . = 4.59 0.2 − COB2 0.2 − COB2
Finally, we look at the CO2 disassociation curve P
CO2 CO2 | max
−k6 P
CCO2 = CCO2 / max 1 − e
or,
∗ CCO 2
=1−e
PCO 2 CO2 | max
−k6 P
(25)
, ∗ −k6 PCO
=1−e
2
.
(26)
88 Human Respiration ∗ Based on Fig. 6, when PCO = 2
20 mmHg 38 ∗ = = 0.14, CCO = 0.475, so that 2 140 mmHg 80
0.475 = 1 − e−0.14k6 , ∗ = when PCO 2
k6 = 4.60,
(27)
70 mmHg 60 ∗ = = 0.5, CCO = 0.75, so that 2 140 mmHg 80 0.75 = 1 − e−0.5k6 ,
k6 = 2.77.
(28)
So, we take the average value of k6 : k6 =
(4.60 + 2.77) = 3.69. 2
(29)
Then the CO2 concentration is given (from eqns. (26–29) by:
B = 0.8 1 − e CCO2 = CCO 2
and PCO2
−4.71
0.8 = 29.72 ln B 0.8 − CCO 2
PCO 2 140
(30)
.
(31)
3.4 Sequential procedure to compute DO2 and DCO2 ◦
(1) We first monitor: V (t), V (t), SV (stroke volume), EP (cardiac ejection period), VB and C AB (O and CO concentrations in pre oxygenated COVB , COAB , CCO 2 2 CO2 2 2 2 and post oxygenated blood). (=COVE ) and COVB (=COAE ) into eqn. (3), and (2) We substitute the values of COAB 2 2 2 2 AB VE VB AE the values of CCO2 (=CCO2 ) and CCO2 (=CCO2 ) into eqn. (4). (3) We next determine: Q = SV/ejection period, ◦ − COVB , V O2 (t) = Q COAB 2 2 VB ◦ AB V CO2 (t) = Q CCO2 − CCO . 2 ◦
◦
(32) (33) (34)
(4) We then substitute the expressions for V O2 (t) and V CO2 (t) into the equations al (eqn. (14)) and P al (eqn. (19)). for PO CO2 2 VB (=C AE ) into (5) We substitute the monitored values of COVB (=COAE ) and CCO CO2 2 2 2 AE and P AE . eqns. (25) and (31), to obtain the values of PO CO 2 2 (6) Now, in order to determine the values of the lung gas-exchange parameters al DO2 and DCO2 , we substitute into eqns. (3) and (4) for Q from eqn. (32), PO 2 al VB VB from eqn. (14), PCO2 from eqn. (19), PO2 from eqn. (26), and PCO2 from eqn. (31).
Lung-Gas Composition and Transfer Analysis
89
3.5 Determining DO2 and DCO2 al − P cap = P al − P AB along the Figure 7 illustrates the variation of P O2 = PO O2 O2 O2 2 length (l) of ) the capillary bed. Let l ∗ = l lm . Then we can express: O2 P O2 = Pmax fO2 (l ∗ ).
Then,
O2 Pav
=
O2 Pmax
1
0
∗
fO2 (l ) dl
∗
(35)
O2 = Pmax FO2 .
O
(36)
O
2 = 65 mmHg, we have Based on data [3], since Pav2 = 12 mmHg for Pmax FO2 = 0.185. CO2 We can similarly determine the average value of Pav from Fig. 8 as: ) Let l ∗ = l lm . Then, we can represent Fig. 8 as:
CO2 P CO2 = Pmax fO2 (l ∗ ).
Then,
CO2 Pav
=
O2 Pmax
0
1
∗
fCO2 (l ) dl
∗
CO2 FCO2 . = Pmax
(37)
(38)
Figure 7: Uptake of oxygen by the pulmonary capillary blood. (The curve in this figure was constructed from data in Mihorn and Pulley: Biophys. J., 8: 337,1968). [from Guyton (1971), p. 434.]
90 Human Respiration
Figure 8: Diffusion of carbon dioxide from the pulmonary blood into the alveolus. (The curve in this figure was constructed from data in Mihorn and Pulley: Biophys. J., 8: 337,1968). [from Guyton (1971), p. 435.] CO
CO
Based on data [3], since Pav 2 = 0.5 mmHg for Pmax2 = 5 mmHg, we have FCO2 = 0.1. O2 CO2 and Pav expressions, we can determine the O2 consumption From the Pav and the CO2 production rates, as follows: ◦ VB − C Q COAB O Total O2 consumed V O2 2 2 = = (39) DO2 = O2 O2 O2 Pav Pav Pav ◦ VB − C AB Q CCO CO2 Total CO2 produced V CO2 2 DCO2 = = = . (40) CO2 CO2 CO2 Pav Pav Pav
4 Case studies (A) We monitor the partial pressures blood concentrations of O2 and CO2 as: AE VB COAE = COVB = 0.13, COVE = COAB = 0.18, CCO = CCO = 0.525, 2 2 2 2 2 2 VE AB = CCO = 0.485. CCO 2 2
From eqn. (26), we obtain:
VB PO 2
0.2 = 30.5 ln 0.2 − COVB 2 = 32.02 mmHg.
= 29.72 ln
0.2 0.2 − 0.13
(41)
Lung-Gas Composition and Transfer Analysis
From eqn. (31), we obtain: VB PCO 2
0.8 = 37.94 ln VB 0.8 − CCO 2
= 37.94 ln
0.8 0.8 − 0.525
91
= 40.51 mmHg.
(42) ◦
◦
We now also monitor Q = 5 l/min, V ∗ = 0.1 and V = 5 l/min. Then, from eqn. (33): ◦ VB , − C V O2 (t) = Q COAB O 2 2 so that from the above data, ◦
V O2 (t) = 5000 × 0.05 = 250 ml O2 /min Consumption rate
(43)
From eqn. (34): ◦ VB AB V CO2 (t) = Q CCO = 5000(0.04) − CCO 2 2 = 200 ml CO2 /min production rate.
(44)
Now, from eqn. (14). ◦ ◦ al : For V ∗ = 0.1 and V O2 = 0.25 l, we obtain PO 2
◦ (◦ −4.18 V ∗ V O2
,
al PO = 140 1 − e 2
= 140 1 − e−4.18[0.1/0.25] = 113.7 mmHg. ◦
(45)
◦
al : From eqn. (19), for V ∗ = 0.1 and V CO2 = 0.20 l, we obtain PCO 2
al = 107.18e PO 2
◦ (◦ −2.19 V ∗ V CO2
= 107.18e−2.19[0.1/0.2]
= 35.86 mmHg.
(46)
Now, we can evaluate the diffusion coefficients: From eqns. (3), (36), (41), and (45): D O2 =
− COVB ) Q(COAB 2 2 O
Pav2 5000(0.18 − 0.13) = = 16.84 ml O2 /min/mmHg. (113.7 − 31.2) × 0.18
(47)
92 Human Respiration From eqn. (4): DCO2 =
VB − C AB ) Q(CCO CO2 2
CO2 Pav 5000(0.04) = 430.11 ml CO2 /min/mmHg. = (40.51 − 35.86) × 0.1
(48)
(B) Alternately, we derive data from: (i) the inspired and expired air analysis (such as that carried out in Section 2.3): O2 consumption rate = 283.2 ml/min, CO2 production rate = 226.8 ml/min, al = 103.03 mmHg and P al = 38.41 mmHg PO CO2 2 and (ii) venous blood gas analysis: VB COVB = 0.13, CCO = 0.548. 2 2
Then, as per eqn. (41), VB = 31.2 mmHg, PO 2
(49)
= 0.13 and, as per eqn. (42): corresponding to COVB 2
0.8 0.8 VB PCO2 = 37.94 ln = 37.94 ln VB 0.8 − 0.548 0.8 − CCO 2 = 43.84 mmHg.
(50) ◦
We obtain, from air-composition analysis, that V O2 (t) = 283.3 ml/min ◦
and V CO2 (t) = 226.8 ml/min.
(51) (52)
Hence, ◦
DO2 = =
V O2 O2 Pav
283.2 = 21.90 mlO2 /min/mmHg, (103.03 − 31.2) × 0.18
(53)
and ◦
DCO2 = =
V CO2 CO2 Pav
226.8 = 417.68 mlCO2 /min/mmHg. (43.84 − 38.41) × 0.1
(54)
The advantage of this method (B) over (A) is that it does not require monitoring of the cardiac output, and is hence simpler to implement clinically.
Lung-Gas Composition and Transfer Analysis
93
References [1]
Guyton, A.C., M.D. Text Book of Medical Physiology, 8th edn, HBJ I.E. Saunders, ISBN 0-7216-3994-1, pp. 422–442, 1991. [2] Comroe, J.H., Physiology of Respiration, 2nd edn, Year Book Medical Publishers Incorporated, ISBN 0-8251-1827-9, pp. 268–269, 1977. [3] Conney, D.O., Biomedical Engineering Principles, Marcel Dekker Inc., ISBN 0-8247-6347-5, pp. 248–251, 342–397, 1976.
This page intentionally left blank
CHAPTER 4 Lung ventilation modeling and assessment D.N. Ghista1 , K.M. Loh2 , & M. Damodaran1 1 School
of Mechanical and Production Engineering, Nanyang Technological University, Singapore. 2 School of Engineering (Electronics), Nanyang Polytechnic, Singapore.
Abstract We have developed a lung-ventilation model by modeling the lung-volume response to mouth minus pleural driving pressure (by means of first- and second-order differential equations) in terms of resistance to airflow (R) and the lung compliance (C). The lung-volume solution of the differential equation is matched with the clinicalvolume data, to evaluate the parameters, R and C. These parameter values can help us to distinguish an obstructive lung and a lung with stiffened parenchyma from a normal lung, and hence diagnose lung diseases such as asthma and emphysema. We have also formulated a nonlinear compliance lung model, and demonstrated deceased lung compliance with filling volume. We then formulated a nondimensional lung-ventilatory index (VTI ), incorporating the parameters R and C as well as the lung-breathing rate. When the VTI is evaluated for various lung diseases, it will conveniently enable us to diagnose lung diseases in terms of just one VTI number. Finally, we have shown how to model a two-lobe lung, and differentiate between normal and diseased lobes.
1 Introduction 1.1 Role of lung ventilation Lung ventilation constitutes inhalation of an appropriate air volume under driving pressure (=mouth pressure − pleural pressure), so as to: (i) provide an adequate alveolar O2 amount at an appropriate partial pressure, (ii) oxygenate the pulmonary blood, and (iii) thereby provide adequate metabolic oxygen to the cells.
96 Human Respiration
T
Diaphragm
Pel R
T
Po
V,Pa
Air
Pp: pleural pressure
Figure 1: Alveolar model.
Hence, ventilatory function and performance assessment entails determining how much air volume is provided to the alveoli, to make available adequate alveolar oxygen for blood oxygenation and cellular respiration. Based on Fig. 1, we get: (i) (ii) (iii) (iv) (v)
(Pa – Pp ) − Pel = 0 Pel = (2ah)/Rr = 2T /r = V /C + Pel0 (Pm – Pa ) = R(dV /dt) PL = Pm – Pp R(dV /dt)+VIC = PL – Pel0 (lung elastic recoil pressure at end of expiration)
2 Lung-ventilation performance using a linear first-order model We first analyze the lung-ventilation function by means of a very simple model represented by a first-order differential equation (Deq ) in lung-volume (V ) dynamics in response to the driving pressure (Pl = atmospheric pressure – pleural pressure), as displayed in Fig. 1. The clinical pressure-volume data is in Fig. 2. The model-governing equation (shown derived in Fig. 1) is as follows: ◦
RV +
V = PL (t) − Pel0 = PN (t), C
(1a)
wherein: (i) the values of pressure are obtained from the given PL (=Pm – Pp ) data (ii) the parameters of this governing Deq are lung compliance (C) and airflow resistance (R); in the equation both R and C are instantaneous values (iii) V = V (t) − Vo (the lung volume at the end of expiration (iv) Pel0 is the lung elastic-recoil pressure at the end of expiration, and Pel0 = Pel −
V . C
(1b)
Lung Ventilation Modeling and Assessment
97
(VT)+0.5
V, Tidal Volume (litres) (FRC) 0
Air-flow resistance is higher during inspiration than expiration.
+0.5 0
V, Air Flow (litres/second)
–0.5 +1
Pa, Alveolar Pressure (cm H2O) 0
The alveolar pressure (Pa) curve is in phase with the air-flow curve. It constitutes the resistance pressure.
–1
Pp, Pleural Pressure (cm H2O) –5
2
1 –7
1
2
–9 0
1
2 3 Seconds
4
5
Figure 2: Lung-ventilatory model and lung-volume and pleural-pressure data. Curve 1 on the curve represents Pel , the pressure required to overcome lung elastance (=V /C). Curve 2 curve represents Pp , the summation of Pel and Pa . The pressure PN (t) in eqn. (1a) equals Pp minus Pel at end of expiration. At the end of expiration when ωt = ωT , PL = Pel0 = PN (t), which is represented by 3 Pi sin (ωi t + ci ), PN (t) = i=1
and the governing eqn. (1a) becomes: V = PN (t) = Pi sin (ωi t + ci ), C 3
◦
RV +
(2a)
i=1
where the right-hand side represents the net driving pressure minus pleural pressure. PN = (Pm −Pp )−Pel0 . This PN is, in fact, the driving pressure (Pm −Pp ) normalized with respect to its value at end of expiration. Eqation (2a) can be rewritten as follows: 1 V = Pi sin (ωi t + ci ), V + RC R ◦
3
i=1
(2b)
98 Human Respiration wherein the P(t) clinical data (displayed in Fig. 2) is assumed to be represented by: P(t) =
3
Pi sin (ωi t + ci ),
(3)
i=1
P1 = 1.581 cmH2 O ω1 = 1.214 rad/s c1 = −0.3132 rad
P2 = −5.534 cmH2 O ω2 = 0.001414 rad/s c2 = 3.297 rad
P3 = 0.5523 cmH2 O ω3 = 2.401 rad/s c3 = −2.381 rad.
The pressure curve (in Fig. 3A) represented by the above eqn. (3) closely matches the pressure data of Fig. 2. If, in eqn. (1), we designate Ra and Ca as the average values (R and C) for the ventilatory cycle, then the solution of eqn. (1) is given by: V (t) =
3 t Pi Ca [sin (ωi t + ci ) − bi Ra Ca cos (ωi t + ci )] − H e− Ra Ca , 2 2 1 + ωi (Ra Ca ) i=1
(4)
wherein the term (Ra Ca ) is denoted by τa . We need to have V = 0 at t = 0. Hence, putting V (at t = 0) = 0, gives us: H=
3 Pi Ca [sin (ωi t + ci ) − bi Ra Ca cos (ωi t + ci )] . 1 + ωi2 (Ra Ca )2 i=1
(5)
Then from eqns. (4) and (5), the overall expressions for V (t) becomes 3 Pi Ca sin (ωi t + ci ) − ωi τa2 cos (ωi t + ci ) V (t) = 1 + ωi2 τa2 i=1 3 Pi Ca sin (ωi t + ci ) − ωi τa2 cos (ωi t + ci ) − t e τa − 2τ2 1 + ω a i i=1
3 t Pi Ca sin (ωi t + ci ) − ωi τa2 cos (ωi t + ci ) = 1 − e− τa . 2 1 + ωi τa2 i=1
(6)
We also want that dV /dt = 0 at t = 0, implying no air-flow at the start of inspiration. So, by differentiating eqn. (6), we get: 3 t Pi Ca ωi cos (ωi t + ci ) + ωi2 τa sin (ωi t + ci ) 1 − e− τa V = 2 1 + ωi τa2 i=1 ◦
3 Pi Ca sin (ωi t + ci ) − ωi τa cos (ωi t + ci ) − t + e τa . 2τ2 τ 1 + ω a i a i=1 ◦
(7)
From eqn. (7), we get V = 0 at t = 0, thereby also satisfying this initial condition.
Lung Ventilation Modeling and Assessment
99
A
B
Figure 3: AThe pressure curve represented by eqn. (3) matched against the pressure data (represented by dots). B The volume curve represented by eqn. (6), for from Ca = 0.2132 (cmH2 O)−1 and Ra = 2.275 cmH2 Osl−1 pp. 3 matched against the volume data represented by dots.
100 Human Respiration Now, by matching the above V (t) expression (6) with the given V (t) data in Fig. 2, and carrying out parameter identification, we can determine the in vivo values of Ra and Ca , to be Ca = 0.2132 (cmH2 O)−1 ,
Ra = 2.275 cmH2 Osl−1
The computed V (t) curve, represented by eqn. (6) for the above values of Ca and Ra , is shown in Fig. 3B. We can however analytically evaluate Ra and Ca by satisfying some conditions. For this purpose, we first note that V is maximum (= tidal volume, t TV) at about t = tV = 2.02 s. At t = tV , the exponential term e− τa in (6) becomes of the order of e−10 , and hence negligible. Then by putting V˙ (t = 2.02) = 0 in eqn. (7), without the exponential term we obtain: 3 Pi Ca ωi cos (ωi × 2.02 + ci ) + ωi2 τa sin (ωi × 2.02 + ci ) ◦ = 0, V |t=2.02 = 1 + ωi2 τa2 i=1 (8) in which the values of Pi , ωi , and ci are given by eqn. (3). Then by solving ◦ eqn. (8), we get τa = 0.522 s. We can also put V = 0 at t ∼ = 1.81/2.87 s and obtain a similar value for τ. Then, we also note that at tv = 2.02 s (at which dV /dt = 0) and V = 0.55 l. Hence upon substituting into eqn. (6), and neglecting the exponential term, we get the following algebraic equation: 3 Pi Ca sin (ωi t + ci ) − ωi τa2 cos (ωi t + ci ) = 2.55Ca , (9) V (t)|t=2.02 = 1 + ωi2 τa2 i=1 by employing the values of Pi , ωi and ci from eqn. (3). Now since V (t = 2.02 s) = 0.55 l, we get 2.55Ca = 0.55 Ca = 0.22 l (cmH2 O)−1 .
(10)
We can substitute, therein, the values of P1 and P2 from eqn. (3), and obtain the value of Ca as: Ca = 0.22 l (cmH2 O)−1 . Since we have computed τa = 0.485 s, therefore Ra = 2.275(cmH2 O)sl−1 . These are the average values of resistance to airflow and lung compliance during the ventilatory cycle shown in Fig. 2. Since lung disease will influence the values of R and C, these parameters can be employed to diagnose lung diseases. For instance in the case of emphysema, the destruction of lung tissue between the alveoli produces a more compliant lung, and hence results in a larger value of C. In asthma, there is increased airway resistance (R) due to contraction of the smooth muscle around the airways. In fibrosis of the lung, the membranes between the alveoli thicken and hence lung compliance (C) decreases. Thus, by determining the normal and diseased ranges of the parameters R and C, we can employ this simple lung-ventilation model for differential diagnosis.
Lung Ventilation Modeling and Assessment
101
3 Ventilatory index Let us, however, formulate just one non dimensional number to serve as a ventilatoryperformance index VTI1 (to characterize ventilatory function), as: VTI1 = [(Ra Ca )(Ventilatory rate in s−1 ) 60]2 = τa2 (BR)2 602 ,
(11)
where BR is the breathing rate. Now, let us obtain its order of magnitude by adopting representative values of Ra and Ca in normal and disease states. Let us take the above computed values of Ra = 2.275 (cmH2 O)sl−1 and Ca = 0.2132 l (cmH2 O)−1 and BR = 12 m−1 or 0.2 s−1 , computed for the data of Fig. 2 and eqn. (3). Then, in a supposed normal situation, the value of VTI1 is of the order of 33.88. In the case of obstructive lung disease, (with increased Ra ), let us take Ra = 5 (cmH2 O)sl−1 , Ca = 0.12 l (cmH2 O)−1 and BR = 0.3 s−1 ; then we get VTI1 = 116.6. For the case of emphysema (with enhanced Ca ), let us take Ra = 2.0 cmH2 Osl−1 , Ca = 0.5 l (cmH2 O)−1 and BR = 0.2 s−1 ; then we obtain VTI1 = 144. In the case of lung fibrosis (with decreased Ca ), we take Ra = 2.0 cmH2 Osl−1 , Ca = 0.08 l (cmH2 O)−1 and BR = 0.2 s−1 ; then we obtain VTI1 = 3.7. We can hence summarize that VTI1 would be in the range of 2–5 in the case of fibrotic lung disease, 5–50 in normal persons, 50–150 in the case of obstructive lung disease and 150–200 for the case of emphysema. This would of course need verification by analyzing a big patient population. Now, all of this analysis requites pleural-pressure data, for which the patient has to be intubated. If now we evaluate the patient in an outpatient clinic, in which we can only monitor lung volume and not the pleural pressure, then can we develop a non invasively obtainable ventilatory index?
3.1 Noninvasively determinable ventilatory index In order to formulate a non-invasively determinable ventilatory index from eqn. (1), we need to recognize that in this case PN (t) (and hence Pi , ω and ci ) will be unknown and we need to redesignate the model parameters and indicate their identification procedure. So we make use of the following features from the volume–time data to facilitate evaluation of the following three parameters: (Pi , Ca ), ωi , ci , and τa . At t = tv = 2.02 s, V is max and dV /dt = 0; hence we rewrite eqn. (9) as: ◦
V |t=2.02
3 (Pi Ca ) ωi cos (2.02 × ωi + ci ) + ωi2 τa sin (2.02 × ωi + ci ) = 0. = 1 + ωi2 τa2 i=1 (12)
102 Human Respiration ◦
Also, at t = tm = 1.82/2.87 s, V = 0. Hence by differentiating eqn. (7), without the exponential term, we obtain: 3 tm (Pi Ca ) − sin (ωi tm + ci )ωi2 + ωi3 τa2 cos (ωi tm + ci ) V (t) = 1 − e− τa 2 1 + ωi τa2 i=1 ◦◦
3 (Pi Ca ) ωi cos (ωi tm + ci ) − ωi2 τa sin (ωi tm + ci ) − tm e τa +2 2τ2 1 + ω τ a i a i=1 3 (Pi Ca ) sin (ωi tm + ci ) − ωi τa2 cos (ωi tm + ci ) − tm e τa = 0. − 2 1 + ω2 τ 2 τ a a i i=1
(13)
Then, at t = 1 s, V1 = 2.02l. From eqn. (6), without the exponential term, this condition yields: 3 (Pi Ca ) − sin (ωi + ci )ωi2 + ωi3 τa2 cos (ωi + ci ) V1 = = 2.02. 1 + ωi2 τa2 i=1 In addition, we can utilize data information concerning Vj at tj ( j = 1 to 8), and put down: 3 (Pi Ca ) − sin (ωi tj + ci )ωi2 + ωi3 τa2 cos (ωi tj + ci ) Vj = ; j=1 1 + ωi2 τa2 i=1
to
8.
(14) From eqns. (12)–(14), we can obtain the values of Pi Ca (but not of P1 , P2 and P3 by themselves), ωi , ci and τa . On the other hand, by also fitting eqn. (6), (without the exponential term) to the V (t) data, we obtain: P1 C = 0.3223
P2 C = 0.3143
P3 C = −0.02269
(15)
ω1 = −1.178
ω2 = 0.5067
ω3 = 1.855
(16)
c1 = 90223
c2 = 0.2242
c3 = −3.961
τa = 0.5535.
(17)
We can now also formulate another noninvasively determinable nondimensional ventilatory index (VTI2 ) in terms of these parameters as follows: VTI2 =
(BR)R[TV ]2 (BR)τ[TV ]2 = . |P1 C||P2 C||P3 C| |P1 P2 P3 C 2 |
(18)
It is seen that VTI2 can in fact be expressed in terms of P1, P2 , P3 and R, C. This VTI2 index can be evaluated by computing the values of (BR) and τ, along with (Pi C), as given by eqn. (17). Then, after evaluating VTI2 for a number of patients, its distribution can enable us to categorize and differentially diagnose patients with various lung disorders and diseases.
Lung Ventilation Modeling and Assessment
103
4 Variations in R and C during a respiratory cycle (towards nonlinear) Thus far, we have adopted the average cyclic values Ca and Ra for our DE q model parameters. However, we expect that C will vary with lung volume (V ), and that ◦ R will perhaps vary with the airflow rate or (V ) or even ω. Hence, for a true representation of the lung properties C and R, let us determine their values for different times during the ventilatory cycle, and compare them with their average values Ca and Ra , so as to make a case for a nonlinear ventilatory-function model. Let us hence compute the instantaneous value of compliance (C) at time (t = tm ), ◦◦ when V = 0. Let us differentiate eqn. (2a), giving: ◦
V RV + Pi Cωi cos (ωi t + ci ). = C ◦◦
3
(19)
i=1
◦
◦◦
Now at about mid-inspiration, when t = tm = 1.18 and V = 0.48 l/s, V = 0 l/s and ◦◦ ◦ V = 0.29 l (based on Fig. 2). By substituting for V , V and V in eqn. (19), we obtain, C = 0.486 l/cmH2 O (compared to its Ca value of 0.21). Now, in order to compute R, we utilize the data information that at tV = 2.02 s we substitute ◦ ◦◦ V = 0 l/s, V = − 0.89 l/s and V = 0.54 l (from the Fig. 2 data) into eqn. (2a), to obtain: ◦◦
RV =
3
Pi ωi cos (ωi t + ci )
i=1 3
Pi ωi cos (ωi t + ci )
i=1
R=
◦◦
.
V
(20)
Substitute C (at tm = 1.18 s) = 0.486 l/cmH2 O in either eqns. (6) or (2b), and obtain R = 1.122 (cmH2 O)sl−1 . This gives us some idea of the order of magnitude of R and C, in comparison to their average values Ca and Ra . We could naturally expect C at t = tm (which is about mid-inspiration) to be higher than its value at the end of inspiration, when the lung is fully inflated. Also, we could expect the flow resistance ◦ to be minimum at the peak of inspiration, when V = 0. ◦ Because C and R are not constant, but a function of V and V , we can hence represent lung compliance (C) and resistance (R) as follows: C = C0 e−kC V
or
E=
1 = E0 eke V C
(21a)
◦
R = R0 ekR V , ◦
(21b)
wherein V can also be varied by having the subjects breathe at different ventilation frequencies (ω).
104 Human Respiration 4.1 Nonlinear compliance We note as per the conventional formulation of compliance, given by eqn. (2) in Fig. 1 as: V Pel = + Pel0 = VE + Pel0 . (22) C In the above formulation, we assume that C and E(=1/C) remains constant throughout the ventilation cycle. However, at the start of inspiration, C = Co at t = 0, and it decreases as the lung volume increases, based on the lung (static) volume vs pressure curve. So let us improve upon this (22) model, by making Pel a nonlinear function of volume, as follows: Pel = Pel0 + VE0 ekV .
(23a)
We can alternatively write eqn. (23) as: Pel = Pel0 + V (E0 + E1 t + E3 t 2 ).
(23b)
Employing the above format of compliance, the governing DEq (1) becomes ◦
RV + VE0 ekV = PL (t) − Pel0 = PN (t) =
3
Pi sin (ωi t + ci ).
(24)
i=1
Again at the end of expiration, Pel0 = intrapulmonary pressure = (P0 + P1 ). Hence eqn. (24) becomes: ◦
RV + VE0 ekV =
3
Pi sin (ωi t + ci )
(25a)
i=1
whose RHS is similar to that of eqn. (2a), and the values of P1 , P2 , and P3 are given by eqn. (3) for the Fig. 2 data. Solving eqn. (25a): ◦
RV + VE0 e
kV
=
3
Pi sin (ωi t + ci ),
i=1
or,
◦
V +
VE0 kV Pi e = sin (ωi t + ci ), R R 3
i=1
or, based on eqn. (23b), ◦
V +
Pi V E0 + E1 t + E2 t 2 = sin (ωi t + ci ). R R 3
i=1
105
Lung Ventilation Modeling and Assessment
This yields: V (t) = e
t(6E0 +3E1 t+2E2 t 2 ) 6R
t
e
u(6E0 +3E1 u+2E2 u2 ) 6R
3 Pi
0
i=1
R
sin (ωi u + ci )du.
(25b)
We could employ this expression for V (t) to fit the clinical V (t) data. However, let us try a simpler approach to evaluate these parameters k and E0 . For this purpose, we again bring to bear the situation that at the end of inspiration, for t = tv = 2.02 s, ◦ we have V = 0 and V = Vmax = TV = 0.55 l. Hence, from Fig. 2 data, and eqns. (3) and (25a), we obtain: (26) 0.55E0 e0.55k = 2.55. ◦◦
Let us now employ the volume data point at which V = 0. For this purpose, we differentiate eqn. (25a), to obtain: Pi Ca ωi E0 kV e (1 + kV ) = cos (ωi t + ci ) R R 3
◦◦
V +
i=1
◦◦
PC ω (1 + kV ) i a i E0 + E1 t + E2 t 2 = cos (ωi t + ci ). R R 3
V +
(27)
i=1
◦◦
From the Fig. 2 data at about mid-inspiration, for which at t = tm = 1.18 s, V = 0, V = 0.29 and P = 2.53, from Fig. 2 data. Substituting these values into eqn. (27), we get: (1 + 0.29k)(E0 + 1.18E1 + 1.39E2 ) = 2.53. (28) Now, in eqns. (26) and (28), we have four unknowns to be identified: k, E0 , E1 , and E2 . Hence we need two more equations, corresponding to two additional time instants. From the values in the following table, ◦
◦◦
t
V
V
V
P
Using eqn.
1.18 2.02 2.87 4.19 4.76
0.29 0.55 0.29 −0.03 −0.02
0.48 0 −0.47 0 0.02
0 −0.89 0 0.16 0
2.53 2.55 0.29 −0.15 −0.06
26 26 28 26 28
we can determine the unknowns: k = −0.13, E0 = 4.98, E1 = −2.24 and E2 = 0.21.
(29)
Hence, by employing the nonlinear formulation, Pel = Pel0 + E0 e−kV ,
(30)
106 Human Respiration we obtain the following expression for nonlinear lung compliance (or elastance): dPel 1 =E= = E0 kekV = 0.65e0.13V . dV C
(31)
Based on this expression, we obtain , for t = tm and V = 0.29 l: E=
1 = 0.67 cmH2 O/l and C = 1.48 l/cm H2 O. C
(32)
Equation (31) can now provide us a more realistic characterization of lung compliance as follows: 1 = 0.65 and C = 1.53 cmH2 O/l At t = 0 and V = 0, we compute E = C 1 At t = tm = 1.18 s and V = 0.29 l, E = = 0.67 and C = 1.48 cmH2 O/l C 1 At t = tv = 2.02 s and V = 0.55 l and E = = 0.70 and C = 1.43 cmH2 O/l C (33) which corresponds to the value of Ca . Our nonlinear formulation of lung compliance, as depicted by eqns. (31) and (33), indicates that compliance decreases from 1.53 cm H2 O/l at the start of inspiration to 1.48 cmH2 O/l at about mid-inspiration, and then to 1.43 cmH2 O/l at the end of inspiration. What this also tells us is that the ventilatory model (1) gives the correct reading of the compliance at Vmax , i.e. at the end of inspiration. At other times of inspiration and expiration, the Ca parameter underestimates the instantaneous value of lung compliance. Now, we could also obtain an analytical solution of eqn. (25) for V (t), and fit the expression for V (t) to the lung-volume data, to evaluate the parameters (i) R, E0 and k for an intubated patient (ii) R, E0 , k and P1 , P2 and P3 for a non-intubated patient in the out-patient clinic. However, this is outside the scope of this chapter.
5 Work of breathing (WOB) This is an important diagnostic index, especially if it can be obtained without intubating the patient and even without using the ventilator. The premise for determining WOB is that the respiratory muscles expand the chest wall during inspiration, thereby lowering the pleural pressure (i.e., making it more negative) below the atmospheric pressure to create a pressure differential from the mouth to the alveoli during inspiration. Then, during expiration, the lung recoils passively. Hence, the work done during a respiratory life cycle, is given by the area of the loop generated by plotting lung volume (V ) versus net driving pressure (Pp ).
Lung Ventilation Modeling and Assessment
107
Figure 4: Plot of pressure versus volume. The area under the curve provides the work done. This plot is shown in Fig. 4. Its area can by obtained graphically, as well as analytically as shown below: T t=T dPp (t) VdPp (t) = V dt (34) WOB = dt 0 0
t=T
= 0
3 Pi Ca sin (ωi t + ci ) − ωi τa2 cos (ωi t + ci ) 1 + ωi2 τa2 i=1 3
Pi ωi cos (ωi t + ci )dt
i=1
=
3 i=1
−Pi Ca cos (ωi T + ci ) + ωi τa sin (ωi T + ci ) − cos ci − ωi τa sin ci . (35) ωi 1 + ωi2 τa2
The above expression for WOB can be evaluated, once the values of Ci and τ (or ωτ) and P1 , P2 and P3 and have been computed (as shown in the previous section). So let us substitute into this equation, the following values associated with eqn. (3). P1 = 1.581 cmH2 O ω1 = 1.214 rad/s c1 = −0.3132 rad
P2 = −5.534 cmH2 O ω2 = 0.001414 rad/s c2 = 3.297 rad
P3 = 0.5523 cmH2 O ω3 = 2.401 rad/s c3 = −2.381 rad.
108 Human Respiration We compute the value of WOB to be 0.9446 (cmH2 O l) in 5 s, or 0.19 cmH2 O l s−1 or 0.14 mmHg l s−1 or 0.02 W, which is equivalent to an oxygen consumption of ◦ about 0.51 ml/min or about 0.18% of the resting V O2 of 28.87 ml/min. This value can be verified by calculating the value of the area of the pressure-volume loop in Fig. 4 which is equal to 0.8 cmH2 O l.
6 Second-order model for single-compartment lung model Let us now consider the dynamic (instead of static) equilibrium of a spherical segment of the lung model in Fig. 1, obtained as (by dividing throughout by the elemental lung area): ◦◦
ms u + (Pp − Pa ) + Pelas = 0,
(36a)
wherein: Pa and Pp are the alveolar and pleural pressures, u is the alveolar-wall displacement, ms = lung mass (M ) per unit surface area = M/4πR2 , (1b) and Pelas =
V 2σh = + Pel0 , R C
(36b)
where: (i) C is in l (cmH2 O)−1 (ii) ms (wall mass per unit surface area or surface density) = ρh, ρ is the density (mass per unit volume) (iii) σ is the wall stress (iv) h and R are the wall thickness and radius of the equivalent-lung model. Now, the displaced alveolar volume, V = 43 π(R + u)3 , from which we get
◦◦
◦◦
V ≈ 4πR2 u .
(37)
Now, from eqn. (1), by putting (i)
Pp − Pa = (Po − Pa ) + (Pp − Po )
and
PL = Po − Pp , ◦
(ii)
so that Pp − Pa = Po − Pa − PL = RV − PL , (38) ◦◦ ◦◦ ◦ MV V M M = ms u¨ = = M ∗V ; M ∗ = 4πR2 4πR2 16π2 R4 16π2 R4 =
ms , 4πR2
(39)
109
Lung Ventilation Modeling and Assessment
we obtain, from eqns. (1), (2) and (3): ◦◦
M ∗ V + (Po − Pa ) +
V = PL − Pel,o ; C
M∗ =
ms M = . 2 4 16π R 4πR2
(40)
◦
Now, putting Po − Pa = RV , we obtain: ◦◦
◦
M ∗ V + RV +
V Pi sin (ωi t + ci ) − Pel0 = PL − Pel0 = C 3
i=1
= PN .
(41)
Since at the end of expiration when ωi t = ωi T for i = 1 to 3 and PL = Pel0 so that Pel0 = 0. In eqn. (6), we have: wherein: M ∗ = ms /4πR2 = ρs h; ρs is the lung volume-density per unit surface area (in Kgm−5 ) and M ∗ is in Kgm−4 ; (ii) the clinical data in Fig. 2 is assumed to be represented by (i)
PN (t) =
3
Pi sin (ωi t + ci )
with
(42)
i=1
P1 = 1.581 cmH2 O ω1 = 1.214 rad/s c1 = −0.3132 rad
P2 = −5.534 cmH2 O ω2 = 0.001414 rad/s c2 = 3.297 rad
P3 = 0.5523 cmH2 O ω3 = 2.401 rad/s c3 = −2.381 rad.
Then we can rewrite eqn. (6) as: ◦◦
V +
R M∗
◦
V +
Pi V = sin (ωi t + ci ), CM ∗ M∗ 3
(43a)
i=1
or as: ◦◦
◦
V + 2nV + p2 V =
3
Qi sin (ωi t + ci ).
(43b)
i=1
In the above equation: (i) the damping coefficient, 2n = R/M ∗ (ii) the natural frequency of the lung-ventilatory cycle, p2 = 1/CM ∗ (iii) Qi = Pi /M ∗ .
(43c)
So the governing eqn. (8) of the lung-ventilatory response to the inhalation pressure has three parameters: M ∗ , R and C (if the lung pressure is also monitored by
110 Human Respiration intubating the patient). The solution of this equation is given by:
V (t) =
3
.
Qi (−2ωi cos (ωi t + ci )n + sin (ωi t + ci )p2 − sin (ωi t + ci )ωi2 ) 4n2 ω2 + p4 − 2p2 ω2 i=1 1 1 − 1/2Qi −(n2 − p2 ) 2 ci sin ωi2 + p2 (n2 − p2 ) 2 sin ci − 2ωi n2 cos ci 1
+ p2 n sin ci − 2ωi n(n2 − p2 ) 2 cos ci − ωi3 cos ci + ωi2 n sin ci 1 2 + ωi p2 cos ci e − n− −(p−n)(p+n) t / 0 2 2 2 2 12 4 2 2 4 (n − p ) 4n ωi + p − 2p ωi + ωi +
3
1/2
1
−p2 (n2 − p2 ) 2 sin ci + np2 sin ci + ωi cos ci p2
i=1 1
+ ωi2 n sin ci − 2ωi n2 cos ci + 2ωi n(n2 − p2 ) 2 cos ci 1 1 2 + ωi2 (n2 − p2 ) 2 sin ci − ωi3 cos ci e −(n−(−(p−n)(p+n) )t 1 1 . (n2 − p2 ) 2 4n2 ωi2 + p4 − 2p2 ωi2 + ωi4
(44)
We will ignore the exponential terms and perform parameters identification by matching the above expression for V (t) to the clinical data, shown in Fig. 2. The matching is illustrated in Fig. 5, wherein the first- and second-order differential equation solutions for V (t) are depicted. The computed values of the model parameters are also shown in the table below the figure. Further, the first- and second-order model values of R and C are compared in the table. Let us compare these values with those obtained by simulating the first-order model to the clinical data.
7 Two-compartmental linear model Now, it is possible that only one of the two lungs (or lung lobes) may be diseased. So, let us develop a procedure to distinguish between the normal lung and the pathological lung? We hence employ the 2-compartment model (based on our firstorder differential equation of lung ventilatory function) to solve the problem of a two-lung model (schematized in Fig. 6). For this purpose we make the subject breath at different values of frequency (ω), and monitor the total lung pressure PiT (t) (i.e., P1i and P2i ) and total lung volume Vi (t). Correspondingly, we have PiL (t), and ViL (t) and PiR (t) and ViR (t) for the left and right lungs, respectively. The governing equations will be as follows
Lung Ventilation Modeling and Assessment
R [cmH2 O l−1 s] C [l/cmH2 O] M∗ [cmH2O l−1 s2 ] R n = ∗ [s−1 ] M 1 2 [s−2 ] p = CM ∗
First order model
Second order model
2.28 0.21
3.44 0.85 3.02
111
1.14 0.39
Figure 5: Results of single compartmental model based on differentiate equation formulation, compared with the first-order differential equation model. (refer to Fig. 3) PT = Pl = PR,
i.e. P1T = P1l = P1R
&
P2T = P2l = P2R
VT = Vl + Vr
(45) (46)
corresponding to ωi ; wherein (i)
V l (t) = f (ω, Rl , C l , P T (t))
(47)
(ii)
V R (t) = f (ω, Rr , C r , P T (t)).
(48)
In these equations (20), (i) the variables ω, PT (t), V T (t) are deemed to be known, i.e. monitored. (ii) the parameters Rl , C l , and Rr , C r are to be evaluated.
112 Human Respiration
Figure 6: Schematic of two-compartment first-order lung-ventilation model.
Using the first-order differential equation model, (presented in sect. 2, as given by eqn. (6) or (14): 3 (Pi Ca ) −sin (ωi t + ci )ωi2 + ωi3 τa2 cos (ωi t + ci ) . V (t) = 1 + ωi2 τ 2 i=1
(49)
We put down the expression for V T (t) = V L (CL , τL ) + V R (CR, τR ), match it with the volume data (using a parameter-identification technique (software), to obtain the values of (CL , τL ) and (CR, τR ) by means of which we can differentially diagnose left and right lung lobes’ ventilatory capacities and assosciated disorders (or diseases). 7.1 Two compartmental model using first-order ventilatory model Using eqn. (6) without the exponential term, we put down the expression for the total lung volume equal to the sum of left and right lung volumes, as follows: 3 Pi CL sin (ωi t + ci ) − ωi τL2 cos (ωi t + ci ) V (t) = 1 + ωi2 τL2 i=1 3 Pi CR sin (ωi t + ci ) − ωi τR2 cos (ωi t + ci ) , + 1 + ωi2 τR2 i=1
(50)
Lung Ventilation Modeling and Assessment
113
Two compartmental model First order model
R [cmH2 O l−1 s] C [l/cmH2 O] VTL1 VTL2
Left lung
Right lung
1.137 0.1066 2.115 0.2198
1.137 0.0533 0.5289 1.0320
Figure 7: Results of the two-compartment model, based on the first-order differential equation model. Based on our assumption of TV L /TV R = 0.92 we have TV L = 0.48 × 0.48 = 0.2304 l and TV R = 0.52 × 0.48 = 0.2496 l. wherein, for the clinical data, we have: P1 = 1.581 cmH2 O ω1 = 1.214 rad/s c1 = −0.3132 rad
P2 = −5.534 cmH2 O ω2 = 0.001414 rad/s c2 = 3.297 rad
P3 = 0.5523 cmH2 O ω3 = 2.401 rad/s c3 = −2.381 rad.
We further assume that the ratio of TV of the left lung to that of the right lung is 0.92. Now, in order to develop a measure of confidence in our analysis, we first generate the total lung-volume data by assuming different values of C and R for left
114 Human Respiration
Two compartmental model First order model
R [cmH2 O l−1 s] C [l/cmH2 O] VTL1 VTL2
Left lung
Right lung
1.138 0.1066 2.1192 0.3553
2.276 0.1066 8.4766 0.8341
Figure 8: Results of the two-compartment model, based on the first-order differential equation model. Based on our assumption of TV L /TV R = 0.92 we have TV L = 0.48 × 0.61 = 0.2928 l and TV R = 0.52 × 0.61 = 0.3172 l.
and right lung lobes. We then use eqn. (50) along with the above data on pressure and frequency, to generate the total lung-volume data. We adopt this generated lung volume data as the clinical-volume data. We now make our volume-solution expression (eqn. (50)) match this generated clinical-volume data, by means of the parameter-identification procedures, to evaluate C and R for the left and right lung-lobes and hence VTL1 and VTL2 (eqns. (11) and (18)) for these lobes. Based on the values of VTL1 and VTL2 , we can differentially diagnose the left and right lung lobes.
Lung Ventilation Modeling and Assessment
115
7.1.1 Stiff right lung (with compliance problems) We now simulate a normal left lung and stiff right lung, represented by: RL = RR = 1.14 cmH2 O l−1 s and C L = 0.11, C R = 0.05 l/cmH2 O.
(51)
Substituting these parametric values into eqn. (50), we generate the total lungvolume data, as illustrated in Fig. 7. Now our clinical data for this two-compartment model comprises of the pressure data of Fig. 2 and the generated volume data of Fig. 6. For this clinical data, we match the volume solution given by eqn. (50) with the generated volume data, illustrated in Fig. 7, and carry our parameter identification. The computed values of R and C, listed in the table of Fig. 7, are in close agreement with the initially assumed parametric values of eqn. (51). This lends credibility to our model and to our use of parameter-identification method. Now for differential diagnosis, we compute the lung-ventilatory indices, as shown in the table in Fig. 7. 7.1.2 Right lung with R problems Now, we simulate a lug with an obstructive right lung, as represented by: RL = 1.14 and RR = 2.28 cmH2 O l−1 s and CL = CR = 0.11 l/cmH2 O.
(52)
As in the case of the stiff right lung, we first generate the lung-volume data for the above values of compliance and resistances. We then match the total lung-volume solution given by eqn. (50) with the generated lung-volume data, and compute the compliance and flow resistance values of the right and left lung. These are tabulated in Fig. 8, and found to have good correspondence with the assumed values of eqn. (52).
This page intentionally left blank
CHAPTER 5 Modeling of two-phase flow in the human respiratory system V.V. Kulish1,2 , B. Wijayanto1 & C.S. Lim1,2 1 School
of Mechanical & Production Engineering, Nanyang Technological University, Singapore. 2 Biomedical Engineering Research Centre, Nanyang Technological University, Singapore.
Abstract The presence of solid particles in air flowing through the human respiratory channels influences the gas-exchange process in our lungs. This can be related to the causative effects of various respiratory diseases, such as asthma. In order to model the effects of such particles on the gas-exchange process, we need to know the initial concentration of particles in the alveolar region. Two-phase flow through air passages of the human respiratory system has been simulated for all the 23 bifurcational generations by means of the computational fluid dynamics (CFD) with application of fractal modelling of the duct geometry and description of the flow as a diffusion-like process in the constructed fractal space. The result of the simulation allows us to trace and describe the behavior of solid particles as they appear in the alveoli, where their presence can influence the gas-exchange process. Results showed that only 12% of particles entering the trachea reach the alveolar region and influence the gas exchange. Therefore, it can be concluded that in the respiratory duct, there are zones in which the solid phase accumulates, thus reducing the availability for air (oxygen) to reach the region where the gas exchange occurs.
1 Introduction It is a common belief among the medical community that the presence of solid (or liquid) particles in the breathing air affects diffusion occurring in the alveolar
118 Human Respiration region of human lungs. It is known that these particles affect the gas-exchange process leading either to a negative effect (respiratory diseases) or to a positive one (medication inhalation). However, no quantitative model exists regarding the influence of the second phase on the breathing process. This work aims to present such a model based on two novel bioengineering concepts – fractals and fractional calculus – and, to go further, to find a numerical solution to the problem in question. If the classical means were used, this solution could hardly be achieved. Fortunately, the new formulation allows us to obtain the numerical solution for the concentration of the second phase particles at the entrance of the alveolar region without complications related to nonlinearity of the Navier–Stokes equations. Moreover, the extreme geometrical complexity of the fractal domain was avoided by introducing the fractal time and keeping the space Euclidean. The achieved result is also compared with the result obtained for the same problem by semiclassical means, i.e., by solving the linearised Navier–Stokes equation in the nonmapped domain.
2 Methodology 2.1 Geometry of the human respiratory duct The respiratory duct of a human (Fig. 1) is a system of 23 bifurcating generations of self-similar air passages, whose diameters follow the scaling law: dm = d0 × 2−m/3 ,
(1)
where, d is the passage diameter and m is the number of generation. The detailed view of a single bifurcation is shown in Fig. 3. Note that the length of the duct pipe also follows a scaling law, namely: lm = 0.1L × 2−m/4 ,
(2)
where, L = 0.281, m is the total length of the respiratory duct. Since the bifurcations of the respiratory duct (the domain of interest) are selfsimilar, i.e., follow the scaling (power) law given by eqns. (1) and (2), the domain can be modelled as a fractal whose structure is similar to that of the Cantor set (Fig. 2). The fractals are self-similar structures in which all processes remain invariant with spatial scaling, provided that an appropriate time scaling is performed. Consider now the geometry of a single bifurcation shown in Fig. 3, the opening angle ϕ is uniquely determined by the domain geometry as: cos ϕ =
dm /2 = 2−2/3 . dm+1
(3)
Therefore, ϕ = arccos (2−2/3 ) ≈ 50.95◦ . δm+1 = dm+1 sin ϕ = d0 sin ϕ × 2−(m+1)/3 = 0.01 × 2−m/3 [m].
(4)
Modeling of Two-Phase Flow in the Human Respiratory System
119
Figure 1: Schematic of the respiratory duct. BR – bronchi; BL – bronchioles; TBL – transitional bronchioles; RBL – respiratory bronchioles; AD – alveolar ducts; AS – alveolar sacks; z – generation number; T – terminal generation number (Shields, 1994).
Figure 2: Six generations of the Cantor dust (set).
The upper estimate for the domain length:
= l0 + cos ϕ
17
lm = (12.00 + 2−2/3 × 15.186) × 10−2 = 0.22 [m],
m=1
which is in an excellent accord with the physiological data.
(5)
120 Human Respiration lm+1= lm × 2–1/4
dm+1 = dm × 2–1/3
lm
dm / 2 j
j d
Figure 3: Schematic of a single bifurcation of the respiratory duct (lm and lm + 1 – lengths of the ducts of generations m and m + 1 respectively; dm and dm + 1 – diameters of the ducts of generations m and m + 1, respectively; ϕ – the bifurcation angle; δ – the bifurcation length).
2.2 Self-similarity of the flow through the human respiratory duct Since the velocity field is uniquely determined by the domain geometry (which is fractal), it must follow a certain power law, i.e., be self-similar at different scales. This is really the case. From continuity, the following expression must hold: N (m)vm Am = v0 A0 = V˙ ,
(6)
where, vm is the average velocity through a single branch of the mth generation, N (m) = 2m is the number of branches depending on the generation number, Am = (πdm2 )/4 = A0 × 2−2m/3 is, according to eqn. (1), the cross-sectional area of a single branch, and V˙ is the volumetric gas uptake by humans. Therefore, the velocity indeed follows the power law: vm = v0 × 2−m/3 =
V˙ × 2−m/3 , A0
(7)
and, thus, reflects the fractionality of the domain. However, in order to answer the question about self-similarity of the velocity field, it is first necessary to answer the question about the level of organisation of the flow from scale to scale. If the flow is chaotic, its pattern might not be conserved from scale to scale, and, hence, the velocity field might not be self-similar. If, however, the flow is well organised, its pattern, after being scaled, must be the same.
Modeling of Two-Phase Flow in the Human Respiratory System
121
The Reynolds number based on diameter is the criterion of flow organisation. For the domain in question, the Reynolds number follows the power law: Rem =
v m dm = Re0 × 2−2m/3 . ν
(8)
Using the physiological data, i.e., V˙ = 1.25×10−4 m3 /s and d0 = 1.8×10−2 m, one can find Re0 = (4V˙ )/(πνd0 ) = 550 < Recr = 2300. Thus, it is shown that the airflow through the human respiratory duct is laminar and, hence, self-similar at all scales. 2.3 Transformation of the Navier–Stokes equation It was shown, in [1] and [2], that the Navier–Stokes equation written for an irrotational incompressible flow of a constant viscosity fluid, i.e., ∂v 1 + (v∇)v = − ∇p + ν∇ 2 v, ∂t ρ
(9)
can be, by substitution, know as the Cole–Hopf transformation, v = −2ν
∇ψ , ψ
(10)
reduced to the reaction-type diffusion equation (the Einstein–Kolmogorov equation) ∂ψ p − ν∇ 2 ψ = ψ, (11) ∂t 2µ where, ψ is the de Broglie wave function associated with the fluid particle, p is the pressure difference between the local and a certain reference pressure, µ and ν are dynamic and kinematic viscosity, respectively. 2.4 The initial and boundary conditions From eqn. (10), one can derive the expression for the wave function when the velocity is given, that is, xi 1 (12) v(ξi )d ξi , ψ(xi ) = K exp − 2ν x0 where, xi and ξi denote an independent variable and the corresponding dummy variable, respectively. Therefore, if the direction of the domain boundary is chosen along a co-ordinate axis, the no-slip condition becomes simply ψ(xi ) = K, where K is an arbitrary constant. Indeed, the de Broglie wave function can be determined to a certain constant only. However, due to the exponential nature of the relation between this function and velocity, this does not affect the velocity value itself. So, the constant K can be chosen arbitrarily. Nevertheless, since the wave function,
122 Human Respiration in fact, determines the probability of locating a moving particle in a certain place, such that this probability must decrease as the particle’s velocity increases, it is quite reasonable to choose K = 1 for a particle whose velocity is zero. Consequently, the initial condition, if started with the fluid at rest, is also ψ(xi ) = K. Here, care must be taken in order for the constant K chosen for the no-slip condition, to be of the same value as that chosen for the initial condition. Finally, in order to transform the entrance condition, one has to directly use this condition in eqn. (12) to determine the corresponding wave function. 2.5 Computation of the velocity field In order to compute the velocity field, eqn. (11) was discretised with the Laplacian written in cylindrical co-ordinates and, taking into account the flow symmetry, such that ∂/∂θ ≡ 0. The pressure was modelled as the time-dependent function of the form p = p0 (z/) sin (πt/τ), where, according to the physiological data, p0 = 200 Pa (the maximum pressure difference during the breathing cycle), τ = 2 s is the duration of the breathing in phase, is determined from eqn. (5), and z is the discretisation step in the z direction (parallel to the symmetry axis of the domain). The no-slip condition was imposed as ψ = 1 on the solid boundaries of the respiratory duct and, consequently, the initial condition was chosen ψ = 1 everywhere in the domain at t = 0. As for the boundary condition at the entrance, the values of the wave function there were determined from eqn. (10) for the parabolic velocity profile vz (0, r) = vz,max (1 − 4(r/d0 )2 ) and then: ψ 0, rj ≈ ψ 0, rj−1
2ν , 2ν + vz (0, rj )
provided that ψ(0, 0) = 1 due to the no-slip condition. The boundary condition at the outlet was then naturally chosen so that it satisfied the mass-conservation principle. The physical properties of air, necessary for computation, were chosen for the standard atmosphere conditions, i.e., ν = 1.5 × 10−5 m2 /s. The nonhomogeneous diffusion equation (11) was then solved numerically within the domain shown in Fig. 3. After the wave-function field has been computed, the velocity field was restored following the simple algorithm: vz (rj , zi ) ≈ −2ν
ψ(rj , zi−1 ) − ψ(rj , zi ) , ψ(rj , zi )
vr (rj , zi ) ≈ −2ν
ψ(rj , zi ) − ψ(rj−1 , zi ) , ψ(rj , zi )
and
that is, according to the discretisation scheme for eqn. (10).
Modeling of Two-Phase Flow in the Human Respiratory System
123
2.6 Computation of the concentration field The main assumption of the present study was that the solid particles constituting the second phase of the air flow through the human respiratory duct are small enough spheres, i.e., their effective diameter is much smaller than the smallest diameter of a single branch of the duct. Besides, these particles have no slip with respect to the flow. Under these conditions, the concentration field can be found by solving ∂C + (v · ∇)C = D∇ 2 C, ∂t
(13)
provided that the velocity field is given and there is no chemical reaction between particles and the air, i.e., these particles behave like a passive constituent of the mixture. In eqn. (13), C is concentration, v the velocity field, and D is the particles diffusivity, which, in general, depends on the nature of the particles. Equation (13) was discretised and solved numerically after imposing the boundary condition C(0, r) = C0 = const for all t, and the initial condition C(z, r) = 0 at t = 0. 2.7 Fractal (fractional) approach to the problem The convection of passive solid particles, which build the second phase of the flow through the human respiratory system, can be described by the generalised diffusion equation derived in [1]: ∂2(1−H ) C = D∇ 2 C, (14) ∂t 2(1−H ) where C is the particle concentration, t denotes time, and D stands for the diffusion coefficient, which equals the kinematic viscosity of the fluid carrier, when convection is treated. The exponent H , called the Hurst–Hölder exponent, is a measure of the persistence of a statistical phenomenon (in the present case – diffusion or Brownian motion). For a certain random process X (t), characterised by the range R(t) of values X over a time interval t and the sample standard deviation S(t), the Hurst–Hölder exponent can be defined by H = log (R/S)/ log (t). If 1/2 < H ≤ 1, the process is persistent, meaning that it continues in its initial direction rather than changes this direction. Therefore, the diffusion is faster than normal. When, however, 0 ≤ H < 1/2 the process is antipersistent, i.e., the process tends to change its direction with each time step rather than continue in the same direction, and therefore the diffusion is slower than normal. Finally, normal diffusion occurs when H = 1/2 and is usually referred to as Brownian motion or white noise. In this case, eqn. (14) reduces to the classical diffusion equation. The classical Brownian motion (or diffusion), B(t), is related to that taking place in a fractal space, BH (t), by means of the fractional differentiation operator [3]: t 1−2H
BH (t) =
d 1/2−H B(t) . dt 1/2−H
(15)
124 Human Respiration The geometry of the bronchial tree is determined by the least possible resistance to airflow in the entire bronchial system. The tree itself is a self-similar fractal structure of the Cantor dust type. The Hurst–Hölder exponent for the respiratory duct of an average human can be determined if the phase shift between the maximum inhaling velocity and the maximum velocity at the alveolar region is known. Then, taking into account that the time variation of the air velocity in the entrance to the respiratory duct and the time variation of the air velocity at the entrance to the alveolar region must be related by the transform expressed by eqn. (15), i.e.,
π sin ωt + 2
1 −H 2
=
d 1/2−H sin [ωt] , dt 1/2−H
(16)
where ω is the inhaling frequency, one can find the value of H for the system in question. Since the value of the Hurst–Hölder exponent has been found, it becomes possible to solve eqn. (14) numerically, keeping in mind that the diffusion coefficient becomes time dependent, i.e., D(t) = Dt 2H −1 , and that the fractional differentiation can be defined by the Riemann–Liouville integral as [4]: t f (τ) d τ 1 d q f (t) = , (17) q dt ( − q) 0 (t − τ)q+1 for any q < 0. Thus, the generalised diffusion equation (14) can be rewritten in the form t 2H −1 D∇ 2 C =
1 ∂2 (H ) ∂t 2
0
t
C dτ , (t − τ)1−H
(18)
which is valid for 0 ≤ H ≤ 1/2. Using the physiological data on breathing of humans, the value of the Hurst– Hölder exponent for the respiratory duct was found to be 0.5383 from eqn. (16). This means that, in spite of the domain fractionality, which always reduces the speed of the diffusion process, this process goes in the respiratory duct faster than normal. This is purely due to the convection effect. In fact, the flow helps the solid phase to penetrate regions far from the entrance in a shorter time. The value of the Hurst exponent, however, is close to 0.5. This shows that in the respiratory duct, there exists a kind of balance between subdiffusion caused by fractionality and superdiffusion caused by convection. Then, eqn. (18) was discretised with the right-hand side operator approximated by the ordinary ∂/∂t in order to obtain the initial guess for the concentration field. The value of the diffusion coefficient, however, changed with time as Dn+1 = Dn (t)0.0766 . The solution was found in a semi-infinite one-dimensional domain with the boundary condition C = const and the initial condition C = 0 for any time t ≤ 0. The solution, found in such a manner, was then compared with the one found by solving eqn. (13), i.e., by the classical approach. The comparison shows an
Modeling of Two-Phase Flow in the Human Respiratory System
125
excellent agreement between the solution obtained in the two different ways. Hence, the result confirms applicability of the fractal (fractional) approach. It is worth mentioning here that the new approach is more effective. First, it does not require the knowledge of the velocity field, which, in fact, is incorporated in the Hurst exponent. The time dependency of the diffusivity also reflects the convection, i.e., the diffusion happens faster than in the case of a motionless medium. Secondly, to solve eqn. (18) numerically is much easier and faster than even a linearised set of the Navier–Stokes equations together with the equation for the concentration field.
3 Results Figure 4 shows the main result of the computation, i.e. time variation of the solid particle concentration at the entrance into the respiratory zone. The time span t = 2 s on Fig. 4, corresponds to the duration of a single inhalation. Then, the concentration value reaches about 12 per cent of the value at the entrance into the respiratory system (duct). Therefore, if one is to simulate the gas-exchange process in the alveolar region in the case of the presence of a solid phase, it has to account for about 12 per cent of the particles totally present at the trachea entrance. Another important conclusion can be drawn from analysis of the nondimensionalised concentration profile in a single branch of the respiratory duct (Fig. 5). One can see that the maximum concentration occurs near the walls, where the velocity tends to zero due to the no-slip condition. Thus, in a single respiratory branch there are zones in which the solid phase accumulates causing the decrease in the area available for the air (oxygen) in order to reach the region where the gas exchange takes place. This situation resembles that happening in the case of stenosis due to the presence of a benign or malignant tumour in the respiratory duct. From Fig. 5, one can see that, as the concentration profile evolves downstream, up to ten per cent of the cross-sectional area of a single respiratory branch becomes “unavailable” for the air. 0.12
Concentration
0.1 0.08 0.06 0.04 0.02 0 0
0.5
1
1.5
time, s
2
Figure 4: Time variation of concentration at the entrance to the respiratory region.
126 Human Respiration
Dimensionless concentration
The typical nondimensionalised velocity profile is shown in Fig. 6. From Fig. 6, one can see that the velocity profile resembles that occurring in the entrance region of a circular pipe, where the flow is not yet fully developed. It is also no surprise that the shape of the concentration profile (see curve A in Fig. 5) resembles the shape of the velocity profile. It can be easily understood, if one recalls the assumptions made regarding solid particles constituting the second phase of the flow. Since there is no slip between these particles and the carrying medium and the particles are very small, they must track the flow pattern. (In this case, the particles behave in a way similar to the light-scattering particles applied in Laser Doppler Anemometry (LDA).)
1 A D K
0.8 0.6 0.4 0.2 0 0
0.2 0.4 0.6 0.8 1 Distance from the duct center / the duct diameter (r/d)
Dimensionless longitudinal velocity
Figure 5: Development of the concentration profile downstream:A – 75%, D – 50%, K – 25% of the distance from the entrance, respectively.
1 0.8 0.6 0.4 0.2 0
0
0.2
0.4
0.6
0.8
1
Distance from the duct center / the duct diameter (r/d)
Figure 6: Nondimensionalised velocity profile (corresponds to 75% of the distance from the entrance).
Modeling of Two-Phase Flow in the Human Respiratory System
127
4 Discussion The task of experimentally determining flow parameters and distribution of passive solid particles in the respiratory duct is nowadays impossible. However, the advanced methods of fractional calculus, combined with the modern means of computational fluid dynamics (CFD), allow us not only to quantitatively predict those parameters but also to visualise the air flow in question. The results obtained by these means can now be used as the initial data necessary for a numerical simulation of the gas-exchange process in alveoli when the presence of solid microparticles is to be taken into account. It is, however, necessary to keep in mind that the proposed model has its limitations. Thus, for instance, the mechanical properties of the respiratory duct (such as its elasticity) are left outside the model. Also, the condition of normal breathing has been considered, that is, the breathing that provides the basic metabolic activity. However, the results may be used to quantitatively estimate the effects of particles on the air flow under the ‘best’ condition of breathing. Thus, if the breathing conditions ‘worsen’, a worse influence of particles must be expected. All this makes our model a limiting case for estimating the influence of the second phase present in the air.
5 Conclusions A novel method for determining the concentration of passive solid particles in the entrance of the alveolar region has been developed. The results of the present work can be used to properly impose the initial conditions necessary to numerically simulate effects of the microscopic particles on the gas-exchange process. It has been found that that the maximum concentration occurs near the walls of a single respiratory branch. Thus, in the respiratory duct, there are zones in which the solid phase accumulates, reducing the availability for air (oxygen) to reach the region where the gas exchange takes place. this reduction of the available area has been found to be ten per cent.
References [1]
Kulish, V.V., Heat and mass diffusion in microscale: fractals, Brownian motion and fractional calculus. Ph.D. Thesis, Mechanical Engineering Department, Southern Methodist University, pp. 126–130, 1999. [2] Kulish V.V. & Lage, J.L., On the relationship between fluid velocity and de Broglie’s wave function and the implications to the Navier-Stokes equation. International Journal of Fluid Dynamics Research, 29(1), pp. 39–54, 2003. [3] Mandelbrot, B.B., The Fractal Geometry of Nature. 3rd edn. Freeman & Co.: New York, pp. 349–357, 1983. [4] Oldham, K.B. & Spanier, J., The Fractional Calculus, Academic Press: New York and London, p. 49, 1974.
This page intentionally left blank
CHAPTER 6 Quantification of human physiological response to toxic substances V. Kulish1 & V. Novozhilov2 1 School
of Mechanical and Production Engineering, Nanyang Technological University, Singapore. 2 Faculty of Engineering and Built Environment, University of Ulster, United Kingdom.
Abstract The work presented here is an attempt to quantify physiological responses of humans to toxic substances that can be present in the breathing air. Based on the Weber–Fechner law and the data available for carbon monoxide (CO), a scale has been proposed that enables quantification of the main symptoms of intoxication. As a result, a number within the range from zero to unity has been assigned to each of such symptoms depending on the dose of CO received by an average healthy human. By this, zero corresponds to the zero capability (death) and unity corresponds to the absence of any intoxication symptoms. Thus, it becomes possible to perform continuous quantification of the intoxication level. Furthermore, it has been demonstrated that the proposed scale may be used for different toxic substances provided that their solubility in water is known.
1 Introduction It is generally agreed that the main toxic products can be divided into two major categories, namely asphyxiants or narcosis-producing products and the irritants, which may be sensory or pulmonary [1, 2]. In many practical cases (e.g., fire safety), only carbon monoxide (CO) and hydrogen cyanide (HCN) – both belong to the first group – have been detected in the combustion products in sufficient concentration to cause significant acute toxic effects [1]. There is little doubt that CO is responsible for a large proportion of the deaths that arise from accidental fires [3]. It combines
130 Human Respiration with hemoglobin in the blood to form carboxyhemoglobin (COHb), which results in a toxic narcosis by reducing the amount of oxygen supplied to the body tissue. Thus,thetoxicityofcarbonmonoxideisprimarilyduetoitsaffinityforhemoglobin in the blood. Even the partial conversion of hemoglobin to carboxyhemoglobin will result in anemic hypoxia. This is particularly marked for the brain tissues and leads to unconsciousness with cerebral depression. The levels of COHb, which produce this incapacitation, are also common in victims surviving exposure to fire. For carbon monoxide, during the early stages as the carboxyhemoglobin concentration builds up in the bloodstream, the effects are minimal. Researchers have found no effect on human psychomotor performance at levels up to 12% COHb. When the significant effects do occur, their onset is sudden, and the degree of incapacitation rapidly becomes severe, so that, by the time the victim is aware that he or she is affected, effective action is probably not possible. Although exposure to HCN ultimately has the same effect as exposure to CO, it acts much more quickly; in addition, while the onset of incapacitation of CO is gradual, that from HCN is rapid [4]. For hydrogen cyanide, although the ultimate effects of exposure, which are unconsciousness with cerebral depression, are similar to those produced by carbon monoxide, the pattern of toxicity during the early stages is very different. HCN is also not held exclusively in the blood, as COHb is, but is instead carried rapidly to the brain. However, the above is not the main reason why the present study concentrates on carbon monoxide. Having an affinity to hemoglobin about 213 times higher than oxygen (infinite saturation of red blood cells), carbon monoxide is used in clinical measurements to characterize the diffusing properties of the alveolar membrane and, by this, to determine the lung-diffusing capacity. This circumstance makes carbon monoxide unique not only for determining diffusion abnormalities in respiratory patients, but it is the only reference gas for quantifying the physiological response to toxic substances that have a finite saturation level with respect to hemoglobin. The main objective of this chapter is to build a scale that enables one to quantify the negative effects caused by toxic materials on human health.
2 Preliminary considerations For carbon monoxide, in order to predict the time to incapacitation the percentage of COHb (%COHb) must be predicted as a function of carbon monoxide in the environment, as well as the activity level, health, and size of the individual. A detailed model of the physiology of COHb resulting from exposure to CO was developed by Coburn, Foster and Cane in 1965, although it has not been applied much by the combustion toxicology community [5]. The two limiting cases of this model are expressed as follows: The initial uptake of CO when the COHb is well below the concentration in the blood. The equilibrium condition.
Quantification of Human Physiological Response to Toxic Substances
131
In the initial uptake regime, the transport of CO into the blood stream is limited by the rate at which CO is transported to the lungs through breathing and the transport of CO across the lung/capillary interface. Under these conditions, the total CO uptake would be expected to be proportional to the concentration of CO, ppm CO in the air breathed, the volume rate of breathing (RMV), and the exposure time. This linear relationship between dose and concentration time is known as Haber’s rule: D = κCt,
(1)
where D is the dose, t is time, and κ is the so-called Haber’s constant. Human experiments by Stewart et al [5] are represented by the expression: %COHb = 3.317 × 10−5 (ppmCO)1.036 (RMV)t.
(2)
The deviation from Haber’s rule for CO is very small. This expression has been shown to be useful in constant concentration environments that would be fatal in one hour or less.
3 Basic definitions and the scale of capability In order to start building the quantitative scale of capability, one has first to identify numerical parameters on which this scale will depend. One such possible candidate is undoubtedly the dose of a toxic substance. This quantity can be defined in an exact mathematical way and measured. Untenable toxicity is defined as the lethal dose of the combustion products at a certain height. This is calculated as: t C(t)dt, (3) D= 0
where D is the toxic dose in % minutes, C is concentration of toxic gas in %, t is time in minutes. For convenience, the operational criterion considers only CO and the lethal dose selected from the literature is 9.0% minutes at 1.9 m above floor level. The definition above is similar to that of untenable temperature, which uses the concept of thermal dose at a certain height. This is calculated as: t H= (T )2 dt, (4) 0
where H is the thermal dose in K2 s, T is temperature rise in K, t is time in seconds. In summary, untenable conditions that can cause death in fires are defined as: CO dose
9.0% minutes (i.e., 90,000 ppm min)
Thermal dose
4000 K2 s.
132 Human Respiration It is obvious that the untenable toxicity can constitute the lower limit of the desired scale. We now prescribe unity to the level of capability corresponding to the healthy state, i.e., when no symptoms of intoxication are present, and denote this level as L. We can now write: LCO (Dthr ) = 1,
(5a)
where Dthr denotes the threshold value of the toxic dose. The threshold value corresponds to the state in which no intoxication symptoms are present and is equal to the normal content of carbon monoxide in the breathing air, i.e., Dthr = 0.009% min. The level of capability corresponding to the lethal outcome of intoxication must be zero, that is (5b) LCO (Dlethal ) = 0, where Dlethal = 9.0% min for carbon monoxide. We now have the necessary two limits to build the scale between them, namely LCO (0) = 1 and LCO (9.0) = 0. Having these, one should look at different incapability effects corresponding to the range of doses between Dthr and Dlethal (see Table 1). The toxic dose can be viewed as an external stimulus to which the human organism responds according to the Weber–Fechner law [6]. The most famous example of the use of this law for building scales of physiological responses is the decibel scale that defines a quantitative measure of the human physiological response to sound. The Weber–Fechner law is simply the information gain due to an external stimulus. Mathematical expression of this law follows from the famous Shannon formula for the informational entropy that, in its turn, is related to the Boltzmann formula for the thermodynamic entropy. In the case considered here, the Weber–Fechner law becomes D LCO (D) = 1 − q log , (6) Dthr where the logarithm base is two, D is the dose of CO in % min, and q is a nondimensional constant defined so as to satisfy the scale limits discussed previously. The value of the proportionality constant q in eqn. (6) may be determined if the value Table 1: Characteristic symptoms of CO intoxication depending on the dose received [5]. Dose of CO, % min
Symptom
0.6 2.0 3.0–4.5 9.0
dizziness headache collapse/unconsciousness death
Quantification of Human Physiological Response to Toxic Substances
133
1 L CO 0.8 dizziness 0.6 headache 0.4 unconsciousness 0.2
death
collapse
0 0
2
4
6
8 D, %min 10
Figure 1: Dependence of the capability degree on the received dose of CO (defined by eqn. (6)). of the lethal dose, Dlethal = 9.0% min, is substituted into eqn. (6) and requiring that LCO (Dlethal ) = 0. It follows then that the value of q must be 0.10034, in order to satisfy this requirement. Then, for a dizziness threshold, for instance, LCO = 0.392; LCO = 0.218 for headache; and 0.100 < LCO < 0.159 for the state of unconsciousness and collapse (see Fig. 1). Now, it is important to note that, by the use of the diffusion and solubility laws [7], it is possible to show that DL-X χX = DL-CO χCO
MCO MX
1/2
χX = 0.0185
28 MX
1/2 = 286.03
χX MX1/2
,
(7)
where DL-X denotes the lung-diffusing capacity with respect to the gas X , χ is the solubility in water (at moderate pressure) and M is the molecular mass of the gas. However, the intoxication effect is proportional to the lung ability to diffuse the intoxicating substance into the blood. Therefore, eqn. (7) gives the coefficient that enables one to compute the physiological response to the gas X , given the physiological response to the same dose of carbon monoxide, i.e., LX (D) = 1 −
DL-X [1 − LCO (D)], DL-CO
(8)
where LCO (D) is given by eqn. (6).
4 Conclusions Based on the Weber–Fechner law and the data available for carbon monoxide (CO), a scale has been proposed that enables quantification of the main symptoms of intoxication. As a result, a number within the range from zero to unity has been
134 Human Respiration assigned to each of such symptoms depending on the dose of CO received by an average healthy human. By this, zero corresponds to the zero capability (death) and unity corresponds to the absence of any intoxication symptoms. Thus, it becomes possible to perform continuous quantification of the intoxication level. Then, inverting the scale, i.e., relating the number corresponding to a certain symptom to the dose of a substance other than CO, it appears possible to compare different toxic substances with respect to their effect on human health conditions. Continuous quantification of intoxication symptoms is important in several ways. First, it allows us to obtain a numerical result during a computer simulation of different health conditions not only in the study of toxic substances, but in a much broader sense (to describe a patient’s conditions numerically). Secondly, it allows, from now on, to avoid a subjective (nonexact) judgment of health conditions, be it by medical diagnostics or by bioengineering research. This first step to the exact – mathematically rigorous – evaluation of health conditions paves a new way towards a better modeling of different cases related to human health and safety. As far as the authors know, no similar approach of evaluating the health symptoms has ever been reported.
References [1]
[2] [3] [4] [5]
[6] [7]
Hartzell, G.E., Priest, D.N. & Switzer, W.G., Proceedings of the First International Symposium on Fire Safety Science, Hemisphere Publishing Company, New York, p. 1059, 1986. Purser, D.A., SFPE Handbook of Fire Protection Engineering, Society of Fire Protection Engineers, Boston, Section 1–14, p. 201, 1988. Anderson, R.A., Watson, A.A. & Harland, W. A., Medical Science Law, 21, p. 175, 1981. Purser, D.A., Grimshaw, P. & Berrill, K.R., Archive of Environmental Health, 39, p. 394, 1984. Beyler, C.L., Fire Dynamics and Chemistry: An Engineering Approach, TMs, Center for Firesafety Studies, Worcester Polytechnic Institute, Worcester MA, 1988. Fechner, G.Th., Elemente der Psychophysik, Ed. Benjamin Rand, 1912. Kulish, V.V., Lage, J.L., Hsia, C.W.H. & Johnson, R.L. Jr., A Porous Medium Model of Alveolar Gas Diffusion. Journal of Porous Medium, 2, 1999.
CHAPTER 7 Anatomically based modeling of pulmonary structure M.H. Tawhai Bioengineering Institute, The University of Auckland, New Zealand.
Abstract Detailed and accurate representation of geometry in computational models of anatomical structures is essential to deliver meaningful results from numerical simulations. Advances in imaging technologies – specifically CT (Computed Tomography) for the lung – means that high-resolution data is now readily available upon which the structure of anatomical computational models can be based. Three major considerations are that 1) model geometry relates directly to individual data, 2) the models are integrative, and 3) the models do not become too large. In this chapter we present methods for constructing anatomically based finite-element models of inter-related pulmonary structures. Segmented human lung-lobe data is fit to highorder elements, and we demonstrate how this model is customized to an individual. By employing high-order elements for the lung-volume mesh, detailed surface geometry is represented using relatively few elements. Finite-element models of the conducting airways are constructed within the lung-lobe model, using a combination of segmented data and a bifurcating-distributive algorithm to generate an airway-consistent mesh. We show how the lung parenchyma can be modeled as a space-filling three-dimensional Voronoi mesh, with a generated geometry consistent with the measured alveolated airway structure. The pulmonary capillaries are generated over the alveolar model, as a two-dimensional Voronoi mesh. The capillary model covers the surface of adjacent alveoli in a continuous network, with a single capillary plexus between the adjacent alveoli. All of the models presented here have been compared extensively with morphometric data, to verify that their geometry is representative of the real pulmonary structure. The models are designed to be integrative: they relate multiple structural systems within the same individual, and their use as computational meshes allows spatial distribution of, for example, air pressure or material properties within the lung.
136 Human Respiration
1 Introduction Advances in medical-imaging technology and computing power provide both highquality data for defining the geometry of pulmonary structures and the means to derive anatomically detailed models. This ‘anatomically based modeling’ approach enables the derivation of geometric models that are specific to an individual, rather than seeking to be representative of the mean population geometry. By developing models that are patient specific, functional predictions can be made for the individual by solution of model systems within the customized geometry. For example, predictions of three-dimensional flow distribution through numerical solution of the Navier–Stokes equations in models of the conducting airways have been shown to be very sensitive to the model branching pattern and the surface geometry [1]. Airway models that are both detailed and subject specific are therefore important for accurate numerical predictions and for understanding the influence of intersubject variability on flow, or on predicted particle transport and deposition. The marked variability that exists in whole-lung geometry between individuals may also influence predictions of soft-tissue deformation, and hence the flow distribution to which it is coupled. An anatomically accurate structure is also important for direct comparison of simulation predictions with regional functional measurements from medical imaging. Finite-element analysis solves model equations over a complex domain by dividing the domain into small ‘elements’ [2]. The discretized domain is referred to as a computational mesh. Because the lungs are comprised of several coupled subsystems – including the airways, the pulmonary circulation, the lymphatic system, and the parenchymal tissue in which the airway and vascular trees are embedded – computational meshes of the lung must vary in structure over a range of scales of interest. The model structure is also dependent on the problem to which it is applied: fluid-flow simulation requires three-dimensional meshes [1], whereas inert-gas mixing [3–5] or airway thermodynamics [6] can be modeled satisfactorily using one-dimensional trees with diameter information. By developing computational meshes of the interdependent structures for a specific individual’s lung geometry, the resulting meshes of the airways, circulation, and tissue are consistent and have anatomically based spatial relationships. This makes the process of coupling functional models within the systems far more straightforward than for models that have been developed independently from different data sets. Creation of a computational mesh of an organ requires a data set that describes either the representative or individual organ structure. For a muscular organ such as the heart it is possible to extract data from post-mortem specimens to develop a generic model [7, 8], or to use MR (Magnetic Resonance) imaging to customize the generic model to an individual [9]. However, these techniques are not suitable for the lung: the delicate structure of the parenchyma precludes ex vivo measurements unless the lung is air dried or similarly preserved, but this alters the lung geometry; and MR imaging does not currently provide adequate anatomical detail for the air-filled lung tissue. The Visible Man project [10] provides a data set from which
Anatomically Based Modeling of Pulmonary Structure
137
it is possible to develop a generic model, however, because the specimen is post mortem the lung geometry is quite deformed. CT imaging provides a high level of anatomical detail for the lung. Current technology provides enough resolution to enable segmentation of the human lung fissures (boundaries between the lobes), a limited number of major airways, and a large number of major blood vessels [11, 12]. A Lung Atlas is currently being collated by an interdisciplinary team of researchers, based upon measures from high-resolution CT imaging [13]. The Lung Atlas aims to describe the structural and functional properties of the healthy male and female lung and its normal range of variation over three decades of human life. CT data from the Lung Atlas project was used for development of the geometric models that are described in this chapter. In Section 2 a geometry-fitting technique is described and applied to fit a highorder volume mesh to the human lobes, then a technique for customizing a generic mesh to low-resolution data is outlined. In Section 3 the same fitting technique is used to fit a high-order surface mesh to CT-segmented major airways. Section 3 also describes the application of a bifurcating-distributive algorithm to generate a mesh that is representative of the branching structure of the nonsegmented conducting airways. In Section 4 a technique is described for modeling the pulmonary parenchymal tissue as a space-filling network of polyhedral cells, and in Section 5 a technique is presented to generate a segmented capillary network over model alveoli.
2 Finite-element models of the human lung lobes The human lungs are typically divided into five lobes: two lobes in the left lung and three lobes in the right lung. The lobes wrap around the heart and fill the pleural cavity. The lobes are wrapped in the visceral membrane, with a small amount of pleural liquid between them. Because the lung tissue is highly deformable, the pleural surface bears ‘imprints’ from the ribs (Fig. 1a) that change in location as the lungs slide over the ribs during ventilation. Simulation of soft-tissue deformation for the whole lung requires development of independent meshes of the lobes, so that the lobes can move freely over each other. Fitting to geometry data that defines the fissures produces meshes of the lobes that sit close to one another along their boundaries. That is, the definition of a single fissure provides data to each lobe at the common interface. 2.1 High-order elements In Fig. 1a the surface geometry of the right-upper and middle lobes from a highresolution CT scan of a human male at 80% TLC (total lung capacity) is shown rendered in 3D from masked lobe images. A coarse linear mesh is shown in the second panel of the figure. To represent the lobe geometry using only a linear mesh would require a vast number of elements, which quickly becomes impractical when applying the mesh in numerical simulations. Therefore to maintain a small mesh
138 Human Respiration (a)
(b)
(c)
Figure 1: A single mesh fit to both the right-upper and right-middle lobes. (a) Rendered surfaces from masked CT images, and data-points generated over the surface; (b) initial linear mesh of both lobes; (c) fitted cubic Hermite mesh showing surface curvature.
size high-order elements can be used to represent the surface curvature far more efficiently. High-order elements use polynomials to introduce boundary curvature. This means that they provide a closer fit to geometry data with fewer elements than the linear mesh, however, they do not guarantee derivative continuity across element boundaries. One element type that exploits both the higher accuracy of polynomials and ensures derivative continuity is the cubic Hermite. The formulation of this element type is detailed in Bradley et al [14]. The meshes described in the current and following section use tri-cubic Hermite elements for the lobes (volume meshes) and bi-cubic Hermite elements for the airway surfaces (surface mesh). 2.2 Geometry-fitting The geometry-fitting technique solves for nodal positions and first-derivative values to minimize the distance between data-points that represent the surface geometry of an object and a finite-element mesh surface [8]. This technique has previously been used to fit models of the heart [8], lungs [15], diaphragm [16], and musculoskeletal system [15]. Geometry-fitting can be applied to surface or volume meshes, but in each case it is only the nodes on the mesh surface that form part of the solution in the method described below. That is, the location of nodes internal to the mesh do not change during the solution. Data-points that are external to the mesh at the start of the fitting process are projected down to the mesh surface, and data-points that are internal are projected outwards.
Anatomically Based Modeling of Pulmonary Structure (a)
(b)
(c)
(d)
139
Figure 2: The geometry-fitting technique. (a) initial linear mesh (3 nodes and 2 line elements) and scatter of data-points; (b) orthogonal projection of datapoints on to mesh surface; (c) intermediate solution for nodal positions and derivatives, and re-projection of data-points; (d) final mesh solution.
The geometry-fitting technique illustrated in Fig. 2 can be summarized in the following steps: 1. Data-points are gathered to describe the geometry of the object’s surface (Fig. 2a). This may necessitate manual image digitization, or imagethresholding techniques to identify the boundary between the structure of interest and the surrounding tissue. Data-points in Fig. 1a were calculated as a random distribution scattered over the rendered 3D surfaces. 2. An initial linear mesh is positioned close to the data-points (Fig. 2a). An appropriate location and structure for the initial mesh is critical for convergence of the fitting solution to a well-constructed final mesh. 3. Each data-point is projected orthogonally onto the closest surface element of the initial mesh (Fig. 2b). The orthogonal projection defines the shortest distance from the point to the surface. The sum of all data-point to surface distances is calculated as the current error in the mesh. 4. Each data-point projection, and therefore the summed error, can be written in terms of nodal coordinates and derivatives. This expression is the objective function that the geometry-fitting solution seeks to minimize. For each element, a linear system of equations is generated by differentiating the objective function with respect to each element parameter, and equating the resulting expression to zero. 5. The system of equations is solved for new nodal coordinates and derivatives, to minimize the objective function and excessive element curvature (Fig. 2c). 6. Steps 3–5 are repeated until the solution converges and the error is small. That is because the mesh location and surface curvature changes during the solution the data-points must be reprojected onto the current mesh surface and an updated objective function formulated for solution. The volume mesh in Fig. 1c results from applying the geometry-fitting technique to the data in Fig. 1a and initial volume mesh in Fig. 1b.
140 Human Respiration 2.3 Mesh customization To create lobe models specific to an individual, the geometry-fitting technique can be reapplied to a new dense data set. For the well-defined CT image boundaries from the Lung Atlas, compilation of a high-resolution data set and geometry-fitting for an individual is straightforward. Although this approach produces a model with generally small error, an alternative technique – the affine transformation of a generic mesh – is more appropriate for sparse or low-resolution data. An affine transformation differs from a rigid-body transformation in that as well as including translation and rotation, it also includes stretching and shearing. Because CT is a high-dose imaging modality the number of scans a patient is subjected to must be limited, hence scanning the entire lung is not always possible. MRI is low dose, but this method generally produces poor anatomical detail for the lung. Sparse data sets from CT and low-resolution data sets from MRI can be used to define target locations for affine transformation of a generic mesh. An affine transformation procedure, also called ‘host-mesh customization’ has been detailed by Fernandez et al [15] for both surface and volume meshes. The method is illustrated in Fig. 3 for a volume mesh, and can be summarized as follows: 1. A generic mesh – with structure representative of the body of interest (the leftupper lobe is shown in Fig. 3a) – is embedded within a host mesh. The host mesh is comprised of one or more volume elements with any specified interpolation function. The example in Fig. 3 uses a single high-order element. For greater accuracy several elements could be used, but the number of landmark and target points required (step 3) would need to increase accordingly. 2. The location of each generic mesh node is calculated with respect to the host mesh. That is, the host element that contains each node is determined and the node’s local (ξ) coordinates with respect to the host element are calculated. 3. Pairs of landmark and target points on the generic mesh and data set, respectively, are identified (Fig. 3b). Target and landmark points are locations that are clearly identifiable on both the image-based data set and the generic mesh. For example the carina, apex or base of each lung, or bifurcation points of airways that are visible inside the lung and have been constructed as part of the generic mesh. 4. An affine transformation of the host mesh is calculated to minimize the sum of the distances between the pairs of target and landmark points (Fig. 3c). 5. The location of the generic mesh is updated by calculating the global position of each node using the ξ coordinates calculated in step 2 and the new global locations of the host nodes and elements (Fig. 3d). The error in an affine transformation of a generic mesh is generally larger than for a full fit of a dense data set, but for sparse or low-resolution data there is little advantage in applying the geometry-fitting technique. The affine transformation can also be used to position and arrange the initial linear mesh before the projection of data-points in the geometry-fitting procedure. The initial mesh structure is very important for geometry-fitting: if a portion of the
Anatomically Based Modeling of Pulmonary Structure
(a)
(c)
141
(b)
(d)
Figure 3: Host-mesh customization technique. (a) An initial generic mesh of the left-upper lobe surrounded by the host mesh (cube); (b) host mesh enclosing landmark points (small crosses) and target locations (black points); (c) transformation of the host mesh; (d) transformation of the generic mesh. initial mesh is positioned far from the data-points, or the initial element sizes are very different, this will persist throughout the fit and the final mesh will have an unsatisfactory structure. By using the affine transformation to position the mesh first, the initial mesh can be forced to sit within the entire data set, and to have elements of similar size.
3 Finite-element models of the conducting airways The conducting airways extend from the trachea to the terminal bronchioles. Beginning with the trachea, each generation bifurcates into two (or occasionally more) child branches of generally unequal diameter, length, and branching angle [17–19].
142 Human Respiration Each terminal bronchiole (the last purely conductive portion of each airway path) supplies a single pulmonary acinus, which is the basic ‘unit’ of gas exchange [20]. The terminal bronchioles are positioned on average at generation 16 [19], but because of branching asymmetry the terminal bronchiole generation ranges from approximately generation 8 to generation 25 [21]. Anatomical studies of airway-branching pattern and dimensions have given rise to two widely used models of the human conducting airways: Weibel’s symmetric model A [19], and Horsfield’s asymmetric model [21]. Both of these models are still in widespread use in computational studies because they summarize detailed anatomical data into idealized constructs that are relatively easy to implement. In Weibel’s symmetric model A the mean length and diameter are presented for an average number of generations from the trachea to the terminal bronchioles, with each generation (N ) having 2N branches (where N = 0 for the trachea). The Weibel symmetric model has been so widely used because it enables the vast conducting airway system to be represented by only 16 branches (one per generation), hence making it feasible to solve equations within a very small anatomically based description of the airway system. With current computer technology we are not limited to solution in such a small system, however, the symmetric model is still preferable for some simulation studies. For example, when investigating inert-gas mixing in the respiratory airways, Paiva and Engel [4] and Dutrieue et al [3] used the symmetric model to introduce an average ‘delay’ in transit of the inspired gas from the mouth to the terminal bronchiole. When it is sufficient to treat the conducting airways as an ‘averaged’ structure, it is preferable to use the symmetric model than the more accurate but computationally expensive asymmetric models. The Horsfield model is based upon the ordering system proposed by Horsfield and Cumming [17]. In Horsfield ordering the terminal airways are order 1 and each parent branch is one order higher than the child branch of highest order. The Horsfield model represents airway-branching asymmetry by , the difference in order of the two child branches. Horsfield et al [21] presented models with constant through the majority of the conducting airway tree (the terminal airways require a slightly different pattern), and models with different values in each lobe or bronchopulmonary segment. Because each terminal branch in the model has a unique connectivity path, the model size cannot be reduced to the extent of the symmetric model. The Horsfield model also does not include the spatial information that is necessary for some studies. Recent computational studies have highlighted the need for accurate anatomically based airway models with spatially distributed branches [6, 22, 23]. Tawhai and Hunter [22] investigated the influence of conducting airway asymmetry on predictions of inert-gas mixing using an anatomically based model. They concluded that while the branching asymmetry did influence the inert-gas dynamics, a more important factor was an accurate description of the flow distribution. However, to accurately predict the distribution of inspired gas requires coupling of the anatomically based model to deformation of the lung during the breathing cycle. To investigate the influence of heterogeneous airway constriction on global measures of lung function, Tgavalekos et al [23] applied constrictions in an anatomically
Anatomically Based Modeling of Pulmonary Structure
143
based airway model, with the location of the constricted airways determined from PET (Positron Emission Tomography) imaging. This type of simulation study can only be performed in a model that has both accurate branching structure and spatial distribution of the airways to link the applied model airway constrictions to the regional PET measures. Tawhai and Hunter [6] have demonstrated that the asymmetry of the branching pattern in the human airways has a significant influence on the rate of heating and humidification in different airway paths when gas is inspired at less than core conditions. Because the location of the airways partly determines the flow through them, the local thermodynamic processes are influenced by the rate of air flow. Therefore this type of study also requires the use of accurate airway models with spatial information. 3.1 Modeling the central conducting airways Advanced segmentation algorithms can uniquely identify human airways down to generation 7, and in some airway paths down to generation 9 [11]. Beyond this level it becomes increasingly difficult to identify the individual airways as the diameters decrease. Therefore to develop models from this limited data set we use a combination of surface-mesh fitting to segmented larger airway data, and an airway-generation algorithm to create centerlines of branches down to the terminal bronchioles. The geometry-fitting technique detailed in Section 2 for the lobes can also be applied to fitting finite element meshes to segmented airway data. Fig. 4 compares two models of several major airways (the first 3 generations): in Fig. 4a the airways are modeled as straight elements, starting and ending at the airway branch points,
(a)
(b)
Figure 4: Models of the trachea and several major bronchi (to generation 3). (a) 1D centerline model with average diameter values for each airway (7 × 1D elements); (b) surface mesh fit to CT data (112 × 2D elements).
144 Human Respiration and with associated mean diameters; in Fig. 4b CT data has been fit to a surface mesh (note that the technique can also be used to fit a volume mesh for the airways, but in the current example only a surface mesh is fit). The second mesh has a more accurate representation of the local surface geometry, whereas the first mesh assumes cylindrical airways with constant cross-sectional area along each branch. The first mesh has the form of the ‘traditional’ airway model. Its structure can be described simply by the location of the branch points, and the diameter of each airway. While the model is small and relatively simple to use, it does not incorporate any change in cross section down the airway, and has discontinuities in cross sections and overlap of the airways at the bifurcations. The second mesh requires storing more information, but it provides a more accurate description of the change in geometry along each airway. The surface mesh can be used in a similar way to the simpler structure in finiteelement simulation studies by integrating the governing equations over the airway cross section. The local area is then used in the formulation of the solution system. 3.2 Modeling the conducting airway tree To model the airway tree from the last segmented airways to the terminal bronchioles, a bifurcating-distributive algorithm can be used to fill the available volume with an asymmetric tree [24]. The algorithm relates the model airways directly to the fit lobe geometry described in Section 2: the airways are generated from the last CT-based airways into each of the fit lobar volume meshes so that the airway lengths, orientation, and branching pattern depend directly on the different lobe shapes. The algorithm generates linear centerlines – no curvature is included. The structure is therefore similar to that shown in Fig. 4a, with straight airways and constant circular cross sections. The algorithm produces only bifurcations: each division is from a single parent into two child branches. Each airway in the unrefined generated tree is a single 1D finite element, and each bifurcation point is the location of a node. The airway algorithm is illustrated in a simple 2D geometry in Fig. 5. Figure 5a shows an initial rect